<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>BMC Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2105</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8729153</article-id>
    <article-id pub-id-type="publisher-id">4548</article-id>
    <article-id pub-id-type="doi">10.1186/s12859-021-04548-z</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Research</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>gGATLDA: lncRNA-disease association prediction based on graph-level graph attention network</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Li</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Zhong</surname>
          <given-names>Cheng</given-names>
        </name>
        <address>
          <email>chzhong@gxu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.79703.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1764 3838</institution-id><institution>School of Computer Science and Engineering, </institution><institution>South China University of Technology, </institution></institution-wrap>Guangzhou, China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.256609.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2254 5798</institution-id><institution>School of Computer, Electronics and Information, </institution><institution>Guangxi University, </institution></institution-wrap>Nanning, China </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.256609.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2254 5798</institution-id><institution>Key Laboratory of Parallel and Distributed Computing in Guangxi Colleges and Universities, </institution><institution>Guangxi University, </institution></institution-wrap>Nanning, China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>4</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>4</day>
      <month>1</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>23</volume>
    <elocation-id>11</elocation-id>
    <history>
      <date date-type="received">
        <day>18</day>
        <month>9</month>
        <year>2021</year>
      </date>
      <date date-type="accepted">
        <day>21</day>
        <month>12</month>
        <year>2021</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2021</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">Long non-coding RNAs (lncRNAs) are related to human diseases by regulating gene expression. Identifying lncRNA-disease associations (LDAs) will contribute to diagnose, treatment, and prognosis of diseases. However, the identification of LDAs by the biological experiments is time-consuming, costly and inefficient. Therefore, the development of efficient and high-accuracy computational methods for predicting LDAs is of great significance.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">In this paper, we propose a novel computational method (gGATLDA) to predict LDAs based on graph-level graph attention network. Firstly, we extract the enclosing subgraphs of each lncRNA-disease pair. Secondly, we construct the feature vectors by integrating lncRNA similarity and disease similarity as node attributes in subgraphs. Finally, we train a graph neural network (GNN) model by feeding the subgraphs and feature vectors to it, and use the trained GNN model to predict lncRNA-disease potential association scores. The experimental results show that our method can achieve higher area under the receiver operation characteristic curve (AUC), area under the precision recall curve (AUPR), accuracy and F1-Score than the state-of-the-art methods in five fold cross-validation. Case studies show that our method can effectively identify lncRNAs associated with breast cancer, gastric cancer, prostate cancer, and renal cancer.</p>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p id="Par3">The experimental results indicate that our method is a useful approach for predicting potential LDAs.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>lncRNA-disease association prediction</kwd>
      <kwd>Graph attention network</kwd>
      <kwd>Gaussian interaction profile kernel similarity of lncRNAs</kwd>
      <kwd>Disease similarity based on gene–gene interaction network</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
            <institution>National Natural Science Foundation of China</institution>
          </institution-wrap>
        </funding-source>
        <award-id>61962004</award-id>
        <principal-award-recipient>
          <name>
            <surname>Zhong</surname>
            <given-names>Cheng</given-names>
          </name>
        </principal-award-recipient>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par10">Long non-coding RNAs (lncRNAs) is a kind of non-protein-coding RNA, which has over 200 nucleotides [<xref ref-type="bibr" rid="CR1">1</xref>]. More and more researches have indicated that the mutations and dysregulations of lncRNAs are closely related to the development and progression of various human complex diseases, including cancer [<xref ref-type="bibr" rid="CR2">2</xref>]. For example, the down-regulation of H19 significantly decreased breast cancer and lung cancer cell clonogenicity and anchorage- independent growth [<xref ref-type="bibr" rid="CR3">3</xref>]. BCYRN1 was increased in non-small cell lung cancer (NSCLC), and its downregulated expression could suppress NSCLC cell proliferation and cell cycle progression by inhibiting the Wnt/βcatenin pathway [<xref ref-type="bibr" rid="CR4">4</xref>]. MALAT-1 was highly expressed in NSCLC [<xref ref-type="bibr" rid="CR5">5</xref>]. LncRNA-IUR family was a key negative regulator of Bcr-Abl- induced tumorigenesis. LncRNA-IUR-5 suppressed Bcr-Abl-mediated tumorigenesis by negatively regulating STAT5-mediated expression of CD71 [<xref ref-type="bibr" rid="CR6">6</xref>]. HOTAIR played a carcinogenic role in different cancers, including breast cancer, gastric cancer, colorectal cancer and cervical cancer cell [<xref ref-type="bibr" rid="CR7">7</xref>]. Preclinical studies indicated that LncRNA-SARCC could attenuate RCC cell invasion, migration and proliferation in vitro and in vivo [<xref ref-type="bibr" rid="CR8">8</xref>]. The specific HOTAIRM1 cytoplasmicisoform HM1-3 was downregulated in over 90% of clear cell renal cell carcinomas (ccRCCs) [<xref ref-type="bibr" rid="CR9">9</xref>].  Therefore, the identification of disease-related lncRNAs will help to understand human complex disease mechanism, disease diagnosis, treatment, prognosis and prevention at lncRNA level.</p>
    <p id="Par11">In recent years, the experimentally supported lncRNA-disease associations are gradually increasing, and these association data have been collected into several databases such as NONCODE [<xref ref-type="bibr" rid="CR10">10</xref>], LncRNADisease [<xref ref-type="bibr" rid="CR11">11</xref>], and Lnc2Cancer [<xref ref-type="bibr" rid="CR12">12</xref>]. However, the known lncRNA-disease associations still involve small part of lncRNA-disease pairs. Due to the biological experiments are expensive and time-consuming, it is very necessary to develop effective and accurate computational method to identify the potential lncRNA-disease associations, which provide the basis for further biological experimental verification.</p>
    <p id="Par12">The existing LDAs prediction methods can be mainly categorized into the network-based methods, machine learning-based methods and matrix factorization-based methods.</p>
    <p id="Par13">The network-based methods construct global heterogeneous network by integrating known LDAs, disease similarities, and lncRNA similarities, and use random walk to identify potential LDAs [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Sun et al. [<xref ref-type="bibr" rid="CR15">15</xref>] proposed a novel LDAs prediction model based on a random walk on an lncRNA functional similarity network, called RWRlncD, to infer potential human LDAs. The limitation of the method was not applicable for lncRNAs that did not have any known associated diseases. Chen et al. [<xref ref-type="bibr" rid="CR16">16</xref>] developed the prediction model KATZLDA using KATZ measure to predict potential lncRNA-disease association on the heterogeneous network. Huang et al. [<xref ref-type="bibr" rid="CR17">17</xref>] developed an improved lncRNA functional similarity calculation model called ILNCSIM to improve prediction performance. Hu et al. [<xref ref-type="bibr" rid="CR18">18</xref>] developed a bi-random walks algorithm BiWalkLDA to predict the LDAs. The bi-random walk referred that the two scores was obtained by performing random walk on disease similarity network and lncRNA similarity network respectively, and then the mean of two scores was used as the prediction result. Li et al. [<xref ref-type="bibr" rid="CR19">19</xref>] proposed a target convergence set based LDAs prediction method, called TCSRWRLD. TCSRWRLD would establish a node set called Target Convergence Set (TCS) for each lncRNA/disease node in the constructed heterogeneous lncRNA-disease network, and an improved random walk with restart (RWR) was implemented on the heterogeneous lncRNA-disease network to infer potential LDAs. TCSRWRLD introduced the concept of TCS, which could effectively accelerate convergence of the algorithm. In order to improve prediction accuracy, some researchers integrated other biological information except lncRNA and disease, such as miRNAs and protein [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. Fan et al. [<xref ref-type="bibr" rid="CR22">22</xref>] developed a method called IDHI-MIRW to predict LDAs. IDHI-MIRW used RWR algorithm on different lncRNA/disease similarities network to obtain the lncRNA/disease topological similarity through the positive pointwise mutual information (PPMI). Then, IDHI-MIRW applied the RWR algorithm on heterogeneous network by integrating the lncRNA/disease topological similarity and the known LDAs to predict the LDAs.</p>
    <p id="Par14">With the application of machine learning and deep learning in Biology [<xref ref-type="bibr" rid="CR23">23</xref>–<xref ref-type="bibr" rid="CR25">25</xref>], some LDAs prediction methods using different machine learning have been proposed, such as Bayesian classifier based prediction method [<xref ref-type="bibr" rid="CR26">26</xref>], random forest based prediction method [<xref ref-type="bibr" rid="CR27">27</xref>], and normal Laplacian regularized least squares based prediction method [<xref ref-type="bibr" rid="CR28">28</xref>]. Chen et al. [<xref ref-type="bibr" rid="CR29">29</xref>] proposed a semi-supervised learning method called LRLSLDA to identify potential associations between lncRNAs and diseases by using Laplacian regularized least squares, which was the first computational model to predict LDAs. LRLSLDA calculated lncRNA similarities and disease similarities, and formulated two classifiers based on Laplacian Regularized Least Squares in the disease space and lncRNA space respectively, and combined these two classifiers into a single classifier to obtain final association probability between disease and lncRNA. Xie et al. [<xref ref-type="bibr" rid="CR30">30</xref>] presented a similarity kernel fusion method to predict LDAs, called SKF-LDA, which also used a normal Laplacian regularized least-squares method. SKF-LDA selected more appropriate fusion method to integrate more biological knowledge to obtain more accurate prediction results. The fusion method built the refined similarity matrices by a neighbor-based constraint and iteration over the similarity matrices instead of a simply weighted addition.</p>
    <p id="Par15">Deep learning has been applied to various prediction problems in Biology [<xref ref-type="bibr" rid="CR31">31</xref>–<xref ref-type="bibr" rid="CR33">33</xref>]. Xuan et al. proposed different deep learning-based lncRNA-disease prediction models, such as CNNLDA [<xref ref-type="bibr" rid="CR34">34</xref>], GCNLDA [<xref ref-type="bibr" rid="CR35">35</xref>], CNNDLP [<xref ref-type="bibr" rid="CR36">36</xref>] and LDAPred [<xref ref-type="bibr" rid="CR37">37</xref>]. CNNLDA used a double convolution neural network based on attention mechanism. GCNLDA used a graph convolution neural network. CNNDLP used convolution neural network and convolution automatic encoder. LDAPred used convolutional neural network and information flow propagation. Wei et al. [<xref ref-type="bibr" rid="CR38">38</xref>] proposed a predictor named iLncRNAdis-FB to identify new LDAs. The method constructed three-dimensional feature blocks of lncRNA-disease pairs by integrating six different biological data, and then used convolutional neural network to predict unknown LDAs. Wang et al. [<xref ref-type="bibr" rid="CR39">39</xref>] developed a multi-label classification with deep forest to predict LDAs. The model implemented multi-label classification by multi-grained scanning and cascade forest. In the multi-grained scanning part, the corresponding transformed feature representation was classified according to different forests. In the cascade forest, layer-wise random forest was used to get more discriminative representations. Yang et al. [<xref ref-type="bibr" rid="CR40">40</xref>] proposed a bidirectional generative adversarial network model called BiGAN, which consisted of an encoder, a generator, and a discriminator. The encoder and generator were used to learn high-level features, the discriminator was used to predict LDAs.</p>
    <p id="Par16">At present, matrix factorization has been applied to identify potential LDAs [<xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR46">46</xref>]. Fu et al. [<xref ref-type="bibr" rid="CR47">47</xref>] developed a matrix factorization based prediction model MFLDA. MFLDA fused the data sources by assigning different weights and decomposed the heterogeneous data sources into low-rank matrices by matrix tri-factorization. Lu et al. [<xref ref-type="bibr" rid="CR48">48</xref>] proposed a LDA prediction method called SIMCLDA based on the inductive matrix completion. The method extracted primary feature vectors from lncRNA similarity and disease similarity by principle components analysis (PCA) respectively, and calculated the interaction profile between a new lncRNA and its neighbors, and completed the association matrix with inductive matrix completion using primary feature vectors and constructed interaction profiles. Compared with traditional matrix factorization-based prediction methods, deep learning based prediction methods can capture non-linear relationship between lncRNAs and diseases. Therefore, some researchers combined matrix factorization with deep learning to improve the performance of predicting LDAs [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>].</p>
    <p id="Par17">Recently, GNNs including graph convolution network and graph attention network have been applied in Bioinformatics [<xref ref-type="bibr" rid="CR51">51</xref>–<xref ref-type="bibr" rid="CR53">53</xref>]. Fan et al. [<xref ref-type="bibr" rid="CR54">54</xref>] proposed a novel computational method GCRFLDA based on the graph convolutional matrix completion. The GCRFLDA integrated conditional random field (CRF) and attention mechanism into the encoder layer to learn the embedding of nodes, and scored potential lncRNA-disease associations. To improve prediction performance, we propose a novel method for predicting potential LDAs based on graph-level graph attention network. The main contributions of this paper are summarized as follows:<list list-type="order"><list-item><p id="Par18">We propose a new disease similarity calculation based on gene–gene interaction network.</p></list-item><list-item><p id="Par19">We propose a novel lncRNA-disease associations prediction method based on graph-level graph attention network.</p></list-item><list-item><p id="Par20">The experimental results show that our method is superior to other state-of-the-art methods in evaluation metrics such as AUC, AUPR, F1-Score, recall, precision and accuracy.</p></list-item></list></p>
    <p id="Par21">The remainder of this paper is organized as follows: Section “Results” shows experimental results. Section “Conclusion” concludes the paper. Section “Datasets and methods” describes our proposed method in detail.</p>
  </sec>
  <sec id="Sec2">
    <title>Results</title>
    <sec id="Sec3">
      <title>Experimental setting</title>
      <p id="Par22">In our study, five fold cross-validation (CV) is conducted on the experiments to evaluate the prediction performance of our method and other methods. Three cross-validation settings are as follows:<list list-type="order"><list-item><p id="Par23">CVP (cross-validation based on the LDA pairs): We randomly partition all experimentally verified LDA pairs into five subsets. In each fold, one subset is used as test set and the other four subsets are used as the training set. The previous training set and test set are positive samples. The unknown lncRNA-disease pairs with the same number of positive samples are randomly selected as negative samples.</p></list-item><list-item><p id="Par24">CVL (cross-validation based on the lncRNAs): We randomly select 20% rows (i.e. lncRNAs) as testing set. The remaining 80% rows (i.e. lncRNAs) are used as training set.</p></list-item><list-item><p id="Par25">CVD (cross-validation based on the diseases): We randomly select 20% columns (i.e. diseases) as testing set. The remaining 80% columns (i.e. diseases) are used as training set.</p></list-item></list></p>
      <p id="Par26">The CVL and CVD methods are designed to evaluate the capability of predicting LDAs for new lncRNAs and new diseases. Each cross-validation is repeatedly conducted for 10 times, and the average of 10 experimental results is used for final result.</p>
    </sec>
    <sec id="Sec4">
      <title>Comparisons with existing works</title>
      <p id="Par27">We compare our method gGATLDA with five state-of-the-art LDAs prediction methods: BiWalkLDA [<xref ref-type="bibr" rid="CR18">18</xref>], MFLDA [<xref ref-type="bibr" rid="CR47">47</xref>], SIMCLDA [<xref ref-type="bibr" rid="CR48">48</xref>], BiGAN [<xref ref-type="bibr" rid="CR40">40</xref>] and GCRFLDA [<xref ref-type="bibr" rid="CR54">54</xref>]. BiWalkLDA performed bi-random walks on lncRNA- disease network integrating interaction profile and gene ontology information to predict LDAs. MFLDA fused different heterogeneous data and predicted new associations using matrix factorization. SIMCLDA was a method for predicting potential LDAs based on inductive matrix completion. BiGAN was an lncRNA-disease association prediction method based on bidirectional generative adversarial network. GCRFLDA was a prediction method based on the graph convolutional matrix completion. We implemented the experimental codes based on deep learning framework Pytorch.</p>
      <p id="Par28">We evaluate our method gGATLDA and other five methods in terms of AUC and AUPR. We select the three different benchmark datasets including different numbers of known LDAs. Dataset1 contained only 621 LDAs, Dataset2 contained 2697 LDAs, and Dataset3 contained 3207 LDAs obtained by merging the Dataset1 and Dataset2. Under three cross-validation settings (CVP, CVL, and CVD), we conduct the experiments on three benchmark datasets respectively. The experimental results are shown in Figs. <xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>Performance comparison of predicting methods under the setting CVP, CVL and CVD on Dataset 1. <bold>a</bold>–<bold>b</bold> Performance of all methods based on the CVP cross-validation settings. <bold>c</bold>–<bold>d</bold> Performance of all methods based on the CVL cross-validation settings. <bold>e</bold>–<bold>f</bold> Performance of all methods based on the CVD cross-validation settings</p></caption><graphic xlink:href="12859_2021_4548_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Performance comparison of predicting methods under the setting CVP, CVL and CVD on Dataset 2. <bold>a</bold>–<bold>b</bold> Performance of all methods based on the CVP cross-validation settings. <bold>c</bold>–<bold>d</bold> Performance of all methods based on the CVL cross-validation settings. <bold>e</bold>–<bold>f</bold> Performance of all methods based on the CVD cross-validation settings</p></caption><graphic xlink:href="12859_2021_4548_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Performance comparison of predicting methods under the setting CVP, CVL and CVD on Dataset 3. <bold>a</bold>–<bold>b</bold> Performance of all methods based on the CVP cross-validation settings. <bold>c</bold>–<bold>d</bold> Performance of all methods based on the CVL cross-validation settings. <bold>e</bold>–<bold>f</bold> Performance of all methods based on the CVD cross-validation settings</p></caption><graphic xlink:href="12859_2021_4548_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par29">As can be seen from Figs. <xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>, our method gGATLDA can achieve the best prediction performance. For example, as shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>a, gGATLDA achieve the highest average AUC of 0.948 under the setting CVP, which is 11.9% higher than the secondly best BiWalkLDA. Figure <xref rid="Fig1" ref-type="fig">1</xref>b show that GATLDA achieve a higher precision with respect to the other five methods for any given recall value. As shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>c, under the CVL and CVD, the AUC and AUPR value of gGATLDA are highest respectively.</p>
      <p id="Par30">On different benchmark datasets, the prediction performance of each method is different. As can be seen from Figs. <xref rid="Fig1" ref-type="fig">1</xref>, <xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>, the prediction performance of our method and SIMCLDA is more stable, and the AUC and AUPR value of our method gGATLDA have higher than that of SIMCLDA on three different datasets. On Dataset1, our method has highest AUC and AUPR. On Dataset2 , the AUC of our method are 3.7%, 10.2%, 15.7%, 16.3% and 55.8% higher than the other five methods GCRFLDA, BiGAN, MFLDA, SIMCLDA and BiWalkLDA respectively. On Dataset3, the AUC of our method are 2.9%, 9.3%, 15.4%, 15.9% and 20.3% higher than the other five methods GCRFLDA, BiGAN, MFLDA, SIMCLDA and BiWalkLDA respectively. The other four methods, such as BiWalkLDA, MFLDA, BiGAN and GCRFLDA, have different prediction performance on different datasets. For example, the AUC of BiGAN is only 0.4847 on Dataset 1, but its AUC value is 0.9042 on Dataset 3 (the latter is about twice the former). BiGAN and GCRFLDA both obtain the highest AUC and AUPR on Dataset 3, which show that the two methods are more suitable for Dataset 3. MFLDA has the lowest values of AUPR on Dataset 1 under the CVP, CVL, and CVD cross-validation settings, which are 0.4993, 0.4697 and 0.4712 respectively. However, on Datasets 2 and 3, the AUPR of MFLDA achieved 0.8891 and 0.9066 respectively. These indicates that MFLDA is sensitive to different datasets. BiWalkLDA perform best on Dataset 1, and perform worst on Dataset 2. Therefore, BiWalkLDA is also sensitive to different datasets.</p>
      <p id="Par31">Different cross validation settings have different influence on the prediction performance of different methods. Under three cross-validation settings, the ROC curve and PR curve of our method are essentially the same. However, the prediction performance of other five methods greatly differs under different cross validation settings. For example, on Dataset1, the AUC of SIMCLDA are 0.8044, 0.4861 and 0.6124 under the CVP, CVL and CVD respectively, while on the Dataset 2, its AUC are 0.8483, 0.6825 and 0.7674 respectively.</p>
      <p id="Par32">In addition to AUC and AUPR, we utilize other evaluation metrics including the F1-score, accuracy, precision and recall to evaluate the performance of our model. Under CVP setting, the experimental results on the three datasets are shown in Tables <xref rid="Tab1" ref-type="table">1</xref>, <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref>. As shown in Table <xref rid="Tab1" ref-type="table">1</xref>, on Dataset 1, our method obtain the highest value of all evaluation metrics such as AUC, AUPR, accuracy, F1-score, recall and precision, which show that gGATLDA can achieve better prediction results on Dataset1. Considering that the number of known associations in Dataset 2 is relatively more, we also compare the different performance evaluation metrics of the six prediction methods on Dataset 2. Table <xref rid="Tab2" ref-type="table">2</xref> show that gGATLDA obtain the best prediction performance. For example, the accuracy of gGATLDA, BiWalkLDA, SIMCLDA, MFLDA, BiGAN and GCRFLDA are 0.9395, 0.4930, 0.7549, 0.7698, 0.8016 and 0.8859 respectively. The F1-score of our method is 0.0661 higher than that of the second ranked method GCRFLDA. Table <xref rid="Tab3" ref-type="table">3</xref> show that evaluation metrics (AUC, AUPR, F1-score and recall) of our method are higher than other five prediction methods on Dataset3. However, the value of the accuracy and precision are lower than GCRFLDA.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Experiment results of six methods on Dataset1 under CVP setting</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">gGATLDA</th><th align="left">BiWalkLDA</th><th align="left">SIMCLDA</th><th align="left">MFLDA</th><th align="left">BiGAN</th><th align="left">GCRFLDA</th></tr></thead><tbody><tr><td align="left">AUC</td><td char="." align="char"><bold>0.9442</bold><inline-formula id="IEq59"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M2"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq59.gif"/></alternatives></inline-formula><bold>0.0025</bold></td><td char="." align="char">0.8435 <inline-formula id="IEq60"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M4"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq60.gif"/></alternatives></inline-formula> 0.0028</td><td char="." align="char">0.7836 <inline-formula id="IEq61"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M6"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq61.gif"/></alternatives></inline-formula> 0.0113</td><td char="." align="char">0.7223 <inline-formula id="IEq62"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M8"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq62.gif"/></alternatives></inline-formula> 0.0118</td><td char="." align="char">0.5246 <inline-formula id="IEq63"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M10"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq63.gif"/></alternatives></inline-formula> 0.0475</td><td char="." align="char">0.8120 <inline-formula id="IEq64"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M12"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq64.gif"/></alternatives></inline-formula> 0.0174</td></tr><tr><td align="left">Precision</td><td char="." align="char"><bold>0.8124</bold><inline-formula id="IEq65"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M14"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq65.gif"/></alternatives></inline-formula><bold>0.0346</bold></td><td char="." align="char">0.7538 <inline-formula id="IEq66"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M16"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq66.gif"/></alternatives></inline-formula> 0.0325</td><td char="." align="char">0.6822 <inline-formula id="IEq67"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M18"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq67.gif"/></alternatives></inline-formula> 0.0832</td><td char="." align="char">0.6928 <inline-formula id="IEq68"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M20"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq68.gif"/></alternatives></inline-formula> 0.1351</td><td char="." align="char">0.4972 <inline-formula id="IEq69"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M22"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq69.gif"/></alternatives></inline-formula> 0.0555</td><td char="." align="char">0.7273 <inline-formula id="IEq70"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M24"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq70.gif"/></alternatives></inline-formula> 0.0197</td></tr><tr><td align="left">Recall</td><td char="." align="char"><bold>0.9029</bold><inline-formula id="IEq71"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M26"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq71.gif"/></alternatives></inline-formula><bold>0.0276</bold></td><td char="." align="char">0.7968 <inline-formula id="IEq72"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M28"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq72.gif"/></alternatives></inline-formula> 0.0135</td><td char="." align="char">0.7591 <inline-formula id="IEq73"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M30"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq73.gif"/></alternatives></inline-formula> 0.0861</td><td char="." align="char">0.6705 <inline-formula id="IEq74"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M32"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq74.gif"/></alternatives></inline-formula> 0.1342</td><td char="." align="char">0.5025 <inline-formula id="IEq75"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M34"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq75.gif"/></alternatives></inline-formula> 0.0759</td><td char="." align="char">0.7025 <inline-formula id="IEq76"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M36"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq76.gif"/></alternatives></inline-formula> 0.0473</td></tr><tr><td align="left">AUPR</td><td char="." align="char"><bold>0.9493</bold><inline-formula id="IEq77"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M38"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq77.gif"/></alternatives></inline-formula><bold>0.0022</bold></td><td char="." align="char">0.8727 <inline-formula id="IEq78"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M40"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq78.gif"/></alternatives></inline-formula> 0.0079</td><td char="." align="char">0.8203 <inline-formula id="IEq79"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M42"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq79.gif"/></alternatives></inline-formula> 0.0125</td><td char="." align="char">0.7895 <inline-formula id="IEq80"><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M44"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq80.gif"/></alternatives></inline-formula> 0.0100</td><td char="." align="char">0.5029 <inline-formula id="IEq81"><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M46"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq81.gif"/></alternatives></inline-formula> 0.0422</td><td char="." align="char">0.7806 <inline-formula id="IEq82"><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M48"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq82.gif"/></alternatives></inline-formula> 0.0236</td></tr><tr><td align="left">Accuracy</td><td char="." align="char"><bold>0.8455</bold><inline-formula id="IEq83"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M50"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq83.gif"/></alternatives></inline-formula><bold>0.0150</bold></td><td char="." align="char">0.7768 <inline-formula id="IEq84"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M52"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq84.gif"/></alternatives></inline-formula> 0.0216</td><td char="." align="char">0.6866 <inline-formula id="IEq85"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M54"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq85.gif"/></alternatives></inline-formula> 0.0546</td><td char="." align="char">0.6432 <inline-formula id="IEq86"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M56"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq86.gif"/></alternatives></inline-formula> 0.0941</td><td char="." align="char">0.4992 <inline-formula id="IEq87"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M58"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq87.gif"/></alternatives></inline-formula> 0.0551</td><td char="." align="char">0.7473 <inline-formula id="IEq88"><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M60"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq88.gif"/></alternatives></inline-formula> 0.0153</td></tr><tr><td align="left">F1-Score</td><td char="." align="char"><bold>0.8541</bold><inline-formula id="IEq89"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M62"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq89.gif"/></alternatives></inline-formula><bold>0.0093</bold></td><td char="." align="char">0.7740 <inline-formula id="IEq90"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M64"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq90.gif"/></alternatives></inline-formula> 0.0128</td><td char="." align="char">0.7087 <inline-formula id="IEq91"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M66"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq91.gif"/></alternatives></inline-formula> 0.0200</td><td char="." align="char">0.6552 <inline-formula id="IEq92"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M68"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq92.gif"/></alternatives></inline-formula> 
0.0205</td><td char="." align="char">0.4995 <inline-formula id="IEq93"><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M70"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq93.gif"/></alternatives></inline-formula> 0.0651</td><td char="." align="char">0.7127 <inline-formula id="IEq94"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M72"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq94.gif"/></alternatives></inline-formula> 0.0323</td></tr></tbody></table><table-wrap-foot><p>The best results in each row are represented in bold</p></table-wrap-foot></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Experiment results of six methods on Dataset2 under CVP setting</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">gGATLDA</th><th align="left">BiWalkLDA</th><th align="left">SIMCLDA</th><th align="left">MFLDA</th><th align="left">BiGAN</th><th align="left">GCRFLDA</th></tr></thead><tbody><tr><td align="left">AUC</td><td char="." align="char"><bold>0.9870 ± 0.0024</bold></td><td char="." align="char">0.6499 ± 0.0022</td><td char="." align="char">0.8433 ± 0.0035</td><td char="." align="char">0.8270 ± 0.0033</td><td char="." align="char">0.8932 ± 0.0118</td><td char="." align="char">0.9548 <inline-formula id="IEq95"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M74"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq95.gif"/></alternatives></inline-formula> 0.0055</td></tr><tr><td align="left">Precision</td><td char="." align="char"><bold>0.9098 ± 0.0136</bold></td><td char="." align="char">0.4958 ± 0.0040</td><td char="." align="char">0.6979 ± 0.0114</td><td char="." align="char">0.9261 ± 0.0368</td><td char="." align="char">0.8031 ± 0.0129</td><td char="." align="char">0.8840 <inline-formula id="IEq96"><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M76"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq96.gif"/></alternatives></inline-formula> 0.0063</td></tr><tr><td align="left">Recall</td><td char="." align="char"><bold>0.9759 ± 0.0068</bold></td><td char="." align="char">0.8466 ± 0.0264</td><td char="." align="char">0.8997 ± 0.0103</td><td char="." align="char">0.5905 ± 0.0646</td><td char="." align="char">0.7990 ± 0.0443</td><td char="." align="char">0.8689 <inline-formula id="IEq97"><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M78"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq97.gif"/></alternatives></inline-formula> 0.0208</td></tr><tr><td align="left">AUPR</td><td char="." align="char"><bold>0.9864 ± 0.0025</bold></td><td char="." align="char">0.7419 ± 0.0036</td><td char="." align="char">0.8824 ± 0.0053</td><td char="." align="char">0.8720 ± 0.0027</td><td char="." align="char">0.8857 ± 0.0200</td><td char="." align="char">0.9512 <inline-formula id="IEq98"><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M80"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq98.gif"/></alternatives></inline-formula> 0.0088</td></tr><tr><td align="left">Accuracy</td><td char="." align="char"><bold>0.9395 ± 0.0083</bold></td><td char="." align="char">0.4930 ± 0.0065</td><td char="." align="char">0.7549 ± 0.0080</td><td char="." align="char">0.7698 ± 0.0166</td><td char="." align="char">0.8016 ± 0.0214</td><td char="." align="char">0.8859 <inline-formula id="IEq99"><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M82"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq99.gif"/></alternatives></inline-formula> 0.0077</td></tr><tr><td align="left">F1-Score</td><td char="." align="char"><bold>0.9416 ± 0.0076</bold></td><td char="." align="char">0.6253 ± 0.0104</td><td char="." align="char">0.7859 ± 0.0041</td><td char="." align="char">0.7174 ± 0.0358</td><td char="." align="char">0.8005 ± 0.0261</td><td char="." align="char">0.8755 <inline-formula id="IEq100"><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M84"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq100.gif"/></alternatives></inline-formula> 0.0125</td></tr></tbody></table><table-wrap-foot><p>The best results in each row are represented in bold</p></table-wrap-foot></table-wrap><table-wrap id="Tab3"><label>Table 3</label><caption><p>Experiment results of six methods on Dataset3 under CVP setting</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">gGATLDA</th><th align="left">BiWalkLDA</th><th align="left">SIMCLDA</th><th align="left">MFLDA</th><th align="left">BiGAN</th><th align="left">GCRFLDA</th></tr></thead><tbody><tr><td align="left">AUC</td><td char="." align="char"><bold>0.9888 ± 0.0065</bold></td><td char="." align="char">0.8185 ± 0.0024</td><td char="." align="char">0.8465 ± 0.0030</td><td char="." align="char">0.8478 ± 0.0048</td><td char="." align="char">0.9045 ± 0.0185</td><td char="." align="char">0.9583 <inline-formula id="IEq101"><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M86"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq101.gif"/></alternatives></inline-formula> 0.0055</td></tr><tr><td align="left">Precision</td><td char="." align="char">0.7980 ± 0.0367</td><td char="." align="char">0.6370 ± 0.0033</td><td char="." align="char">0.7247 ± 0.0142</td><td char="." align="char">0.8667 ± 0.1310</td><td char="." align="char">0.6572 ± 0.0073</td><td char="." align="char"><bold>0.9020</bold><inline-formula id="IEq102"><alternatives><tex-math id="M87">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M88"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq102.gif"/></alternatives></inline-formula><bold>0.0052</bold></td></tr><tr><td align="left">Recall</td><td char="." align="char"><bold>0.9913 ± 0.0078</bold></td><td char="." align="char">0.7297 ± 0.0121</td><td char="." align="char">0.8475 ± 0.0162</td><td char="." align="char">0.6942 ± 0.1089</td><td char="." align="char">0.9495 ± 0.0132</td><td char="." align="char">0.8632 <inline-formula id="IEq103"><alternatives><tex-math id="M89">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M90"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq103.gif"/></alternatives></inline-formula> 00,202</td></tr><tr><td align="left">AUPR</td><td char="." align="char"><bold>0.9890 ± 0.0060</bold></td><td char="." align="char">0.8416 ± 0.0031</td><td char="." align="char">0.8450 ± 0.0053</td><td char="." align="char">0.8860 ± 0.0032</td><td char="." align="char">0.9058 ± 0.0192</td><td char="." align="char">0.9548 <inline-formula id="IEq104"><alternatives><tex-math id="M91">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M92"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq104.gif"/></alternatives></inline-formula> 0.0090</td></tr><tr><td align="left">Accuracy</td><td char="." align="char">0.8670 ± 0.0271</td><td char="." align="char">0.6568 ± 0.0032</td><td char="." align="char">0.7623 ± 0.0065</td><td char="." align="char">0.7652 ± 0.0867</td><td char="." align="char">0.7270 ± 0.0088</td><td char="." align="char"><bold>0.9103</bold><inline-formula id="IEq105"><alternatives><tex-math id="M93">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M94"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq105.gif"/></alternatives></inline-formula><bold>0.0044</bold></td></tr><tr><td align="left">F1-Score</td><td char="." align="char"><bold>0.8830 ± 0.0217</bold></td><td char="." align="char">0.6801 ± 0.0049</td><td char="." align="char">0.7810 ± 0.0022</td><td char="." align="char">0.7523 ± 0.0324</td><td char="." align="char">0.7767 ± 0.0068</td><td char="." align="char">0.8817 <inline-formula id="IEq106"><alternatives><tex-math id="M95">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\pm$$\end{document}</tex-math><mml:math id="M96"><mml:mo>±</mml:mo></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq106.gif"/></alternatives></inline-formula> 0.0130</td></tr></tbody></table><table-wrap-foot><p>The best results in each row are represented in bold</p></table-wrap-foot></table-wrap></p>
      <p id="Par33">In summary, our method outperforms the other five methods in six evaluation metrics such as AUC, AUPR, accuracy, F1-score, recall and precision.</p>
    </sec>
    <sec id="Sec5">
      <title>Comparison of two disease similarities</title>
      <p id="Par34">For the same model, different disease similarities have different effects on the performance of lncRNA-disease association prediction method. In the paper, we propose a new disease similarity calculation based on gene–gene interaction network. In order to evaluate the performance of our proposed disease similarity calculation, we compare it with disease semantic similarity using DAGs on Dataset1 and Dataset2 by evaluation of ROC curves, AUC values, PR curves and AUPR values in the five fold CV experiment. The experimental results are shown in Fig. <xref rid="Fig4" ref-type="fig">4</xref>. We can see from Fig. <xref rid="Fig4" ref-type="fig">4</xref> that for the Dataset2, the AUC and AUPR values of our proposed disease similarity are higher than that of disease semantic similarity, and for the Dataset1, the prediction model using our proposed disease similarity also performed better than the prediction model using disease semantic similarity. It illustrates that the performance of the lncRNA-disease association prediction method using our proposed disease similarity can be improved.<fig id="Fig4"><label>Fig. 4</label><caption><p>Performance comparison of predicting methods using different disease similarity. <bold>a</bold>–<bold>b</bold> For Dataset1, ROC curve and PR curve of predicting methods using different disease similarity. <bold>c</bold>–<bold>d</bold> For Dataset2, ROC curve and PR curve of predicting methods using different disease similarity</p></caption><graphic xlink:href="12859_2021_4548_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec6">
      <title>Influence of different number of hops on the accuracy of the model</title>
      <p id="Par35">GNN explores how to generate node embedding by aggregating neighborhood nodes, most of which are node-level embedding. GNN based on subgraph-level embedding can better learn the local structure of graph to improve performance. Weisfeiler-Lehman Neural Machine (WLNM) method proposed a solution to find the appropriate methods automatically, based on the extracted subgraphs in its neighborhood [<xref ref-type="bibr" rid="CR55">55</xref>]. WLNM used high-order heuristics to achieve significant accuracy. However, high-order heuristics required a large number of hops that span the enclosing subgraphs to the global network, which would lead to additional computation time and memory. SEAL derived γ-decaying theory to infer that a small number of hops was enough to extract the high-order heuristics and achieved better accuracy than WLNM [<xref ref-type="bibr" rid="CR56">56</xref>].</p>
      <p id="Par36">In this study, we focus on whether different hops are influence on the accuracy of the prediction model. We test the effects of different number of hops. We train our model using different number of hops respectively. Table <xref rid="Tab4" ref-type="table">4</xref> show that our model has little difference in performance evaluation metrics for enclosing subgraphs with different number of hops. However, when the number of hops increases, the number of nodes in the subgraph also increases, which will lead to memory and computational overhead. Based on comprehensive consideration, we choose 1-hop enclosing subgraphs in our experiment.<table-wrap id="Tab4"><label>Table 4</label><caption><p>Influence of different hops on the prediction model</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"/><th align="left" colspan="3">Dataset1</th><th align="left" colspan="3">Dataset2</th></tr><tr><th align="left">hop = 1</th><th align="left">hop = 2</th><th align="left">hop = 3</th><th align="left">hop = 1</th><th align="left">hop = 2</th><th align="left">hop = 3</th></tr></thead><tbody><tr><td align="left">AUC</td><td char="." align="char">0.948</td><td char="." align="char">0.943</td><td char="." align="char">0.945</td><td char="." align="char">0.986</td><td char="." align="char">0.982</td><td char="." align="char">0.953</td></tr><tr><td align="left">Precision</td><td char="." align="char">0.731</td><td char="." align="char">0.794</td><td char="." align="char">0.754</td><td char="." align="char">0.658</td><td char="." align="char">0.698</td><td char="." align="char">0.730</td></tr><tr><td align="left">Recall</td><td char="." align="char">0.965</td><td char="." align="char">0.900</td><td char="." align="char">0.926</td><td char="." align="char">0.999</td><td char="." align="char">0.995</td><td char="." align="char">0.988</td></tr><tr><td align="left">AUPR</td><td char="." align="char">0.953</td><td char="." align="char">0.948</td><td char="." align="char">0.951</td><td char="." align="char">0.985</td><td char="." align="char">0.983</td><td char="." align="char">0.950</td></tr><tr><td align="left">Accuracy</td><td char="." align="char">0.799</td><td char="." align="char">0.825</td><td char="." align="char">0.800</td><td char="." align="char">0.732</td><td char="." align="char">0.777</td><td char="." align="char">0.802</td></tr><tr><td align="left">F1-Score</td><td char="." align="char">0.830</td><td char="." align="char">0.838</td><td char="." align="char">0.824</td><td char="." align="char">0.791</td><td char="." align="char">0.819</td><td char="." align="char">0.837</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec7">
      <title>Parameter optimization</title>
      <p id="Par37">Different hyper-parameters will affect the prediction performance of gGATLDA. To obtain the best performance, we have tried a set of different hyper-parameters to find the best hyper-parameter for predicting lncRNA-disease associations. For the parameter dropout, we use the value suggested in most papers, i.e. 0.5. We perform a grid search to optimize three main hyper-parameters, namely, epochs from 10 to 100 with step 10, batch size with the values in {16, 32, 64, 128}, and learning rate with the values in {0.1, 0.01, 0.001}. We respectively tune each parameter combination to calculate the AUC, AUPR, F1-score, accuracy, recall of our model based on five fold cross validation. As shown in Fig. <xref rid="Fig5" ref-type="fig">5</xref>a, the four evaluation metrics including AUC, AUPR, F1-score and recall achieve the best results considering 60 as the number of epochs. From Fig. <xref rid="Fig5" ref-type="fig">5</xref>b and c, we can find that all evaluation metrics obtained the best performance when batch size is 64 and learning rate is 0.001. Finally, the optimal values of hyper-parameters such as learning rate, batch size, and number of training epochs is 0.001, 64 and 60 respectively.<fig id="Fig5"><label>Fig. 5</label><caption><p>Hype-parameter optimization results for F1-score, accuracy, recall, AUC, AUPR. <bold>a</bold> Results comparing different epochs. <bold>b</bold> Results comparing different batch size. <bold>c</bold> Results comparing different learning rate</p></caption><graphic xlink:href="12859_2021_4548_Fig5_HTML" id="MO5"/></fig></p>
    </sec>
    <sec id="Sec8">
      <title>Case study</title>
      <p id="Par38">For further confirming the effectiveness of gGATLDA, we conduct case studies on four diseases, i.e., breast cancer, gastric cancer, prostate cancer, and renal cancer. All the known LDAs in Dataset1 are used as training samples, and other unknown associations are regarded as candidate associations for validation. For the investigated disease <italic>d</italic>, all lncRNAs unassociated with disease <italic>d</italic> are considered as candidate lncRNAs. We rank the candidate lncRNAs according to their predicted scores, and select the top 15 ones to verify whether associated with diseases based on two databases, namely, Lnc2Cancer and LncRNADisease v2.0. For those predicted results that are not been included in the Lnc2Cancer and LncRNADisease, we manually check in PubMed and list the supportive literatures. Moreover, in order to verify the effectiveness of our proposed disease similarity calculation method, we compare the two different disease similarities in the case studies. The validation results are shown in Tables <xref rid="Tab5" ref-type="table">5</xref>, <xref rid="Tab6" ref-type="table">6</xref>, <xref rid="Tab7" ref-type="table">7</xref> and <xref rid="Tab8" ref-type="table">8</xref>. As can be seen from Tables <xref rid="Tab5" ref-type="table">5</xref>–<xref rid="Tab8" ref-type="table">8</xref> that in each case study, the verified proportion of the top 15 candidate lncRNAs obtained using our disease similarity is higher than that using disease semantic similarity.</p>
      <p id="Par39">Breast neoplasms is one of the most common female cancers. With the development of cancer research, lncRNAs have become an essential target for breast cancer prevention, diagnosis, and treatment. The top 15 predicted lncRNAs were experimentally verified by Lnc2Cancer, LncRNADisease v2.0, and published literatures (see Table <xref rid="Tab5" ref-type="table">5</xref>). KCNQ1OT1 is found to be remarkably high expression in breast cancer tissues and cells, which promoted tumor growth in vivo by regulatingmiR-145/CCNE2 [<xref ref-type="bibr" rid="CR57">57</xref>]. CCND1 is associated with cell cycle dysregulation in breast cancer [<xref ref-type="bibr" rid="CR58">58</xref>]. CCND1 is a target of miR-142, and miR-142 inhibited proliferation of endometrial cancer cells by targeting CCND1 [<xref ref-type="bibr" rid="CR59">59</xref>].<table-wrap id="Tab5"><label>Table 5</label><caption><p>Top 15 predicted lncRNAs associated with breast cancer</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="3">Disease similarity based on gene–gene interaction network</th><th align="left" colspan="3">Disease similarity based on disease semantic</th></tr><tr><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">KCNQ1OT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">1</td><td align="left">TRAF3IP2-AS1</td><td align="left">PMID: 30157476</td></tr><tr><td align="left">2</td><td align="left">UCA1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">2</td><td align="left">DLX6-AS1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">3</td><td align="left">MIAT</td><td align="left">Lnc2Cancer 3.0</td><td align="left">3</td><td align="left">MINA</td><td align="left">PMID: 30254753</td></tr><tr><td align="left">4</td><td align="left">MINA</td><td align="left">PMID: 30254753</td><td align="left">4</td><td align="left">KCNQ1OT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">5</td><td align="left">NPTN-IT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">5</td><td align="left">NEAT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">6</td><td align="left">LincRNA-p21</td><td align="left">Lnc2Cancer 3.0</td><td align="left">6</td><td align="left">LincRNA-p21</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">7</td><td align="left">IGF2-AS</td><td align="left">PMID: 33175607</td><td align="left">7</td><td align="left">UCA1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">8</td><td align="left">DRAIC</td><td align="left">LncRNADisease v2.0</td><td align="left">8</td><td align="left">SOX2-OT</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">9</td><td align="left">NEAT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">9</td><td align="left">NPTN-IT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">10</td><td align="left">PCAT29</td><td align="left">PMID: 32521844</td><td align="left">10</td><td align="left">HULC</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">11</td><td align="left">HULC</td><td align="left">Lnc2Cancer 3.0</td><td align="left">11</td><td align="left">CRNDE</td><td align="left">LncRNADisease v2.0</td></tr><tr><td align="left">12</td><td align="left">CCND1</td><td align="left">LncRNADisease v2.0</td><td align="left">12</td><td align="left">TUSC7</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">13</td><td align="left">SPRY4-IT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">13</td><td align="left">7SK</td><td align="left">unconfirmed</td></tr><tr><td align="left">14</td><td align="left">SOX2-OT</td><td align="left">Lnc2Cancer 3.0</td><td align="left">14</td><td align="left">WT1-AS</td><td align="left">LncRNADisease v2.0</td></tr><tr><td align="left">15</td><td align="left">TUSC7</td><td align="left">Lnc2Cancer 3.0</td><td align="left">15</td><td align="left">ESCCAL-1</td><td align="left">unconfirmed</td></tr></tbody></table></table-wrap></p>
      <p id="Par40">Gastric cancer is the fifth most common cancer and the third most common cause of cancer death globally. It is a molecularly and phenotypically highly heterogeneous disease. Multiple evidences demonstrate that lncRNAs play a vital role in gastric cancer resistance to chemotherapy reagents and targeted therapy drugs [<xref ref-type="bibr" rid="CR60">60</xref>]. All top-15 candidate lncRNAs predicted by gGATLDA have confirmed to be associated with gastric cancer (see Table <xref rid="Tab6" ref-type="table">6</xref>). DLX6-AS1 is over-expressed in gastric cancer tissues and cell lines, which regulate tumor growth and aerobic glycolysis in gastric cancer by targeting miR-4290 and PDK1 [<xref ref-type="bibr" rid="CR61">61</xref>].<table-wrap id="Tab6"><label>Table 6</label><caption><p>Top 15 predicted lncRNAs associated with gastric cancer</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="3">Disease similarity based on gene–gene interaction network</th><th align="left" colspan="3">Disease similarity based on disease semantic</th></tr><tr><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">KCNQ1OT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">1</td><td align="left">TRAF3IP2-AS1</td><td align="left">PMID: 25370763</td></tr><tr><td align="left">2</td><td align="left">SOX2-OT</td><td align="left">Lnc2Cancer 3.0</td><td align="left">2</td><td align="left">SOX2-OT</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">3</td><td align="left">LincRNA-p21</td><td align="left">Lnc2Cancer 3.0</td><td align="left">3</td><td align="left">DLX6-AS1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">4</td><td align="left">XIST</td><td align="left">LncRNADisease v2.0</td><td align="left">4</td><td align="left">NEAT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">5</td><td align="left">NPTN-IT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">5</td><td align="left">MALAT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">6</td><td align="left">MIAT</td><td align="left">Lnc2Cancer 3.0</td><td align="left">6</td><td align="left">GAS5</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">7</td><td align="left">DRAIC</td><td align="left">Lnc2Cancer 3.0</td><td align="left">7</td><td align="left">XIST</td><td align="left">LncRNADisease v2.0</td></tr><tr><td align="left">8</td><td align="left">MALAT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">8</td><td align="left">LincRNA-p21</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">9</td><td align="left">HULC</td><td align="left">Lnc2Cancer 3.0</td><td align="left">9</td><td align="left">KCNQ1OT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">10</td><td align="left">IGF2-AS</td><td align="left">PMID: 31183590</td><td align="left">10</td><td align="left">NPTN-IT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">11</td><td align="left">NEAT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">11</td><td align="left">HULC</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">12</td><td align="left">PCAT29</td><td align="left">LncRNADisease v2.0</td><td align="left">12</td><td align="left">TUG1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">13</td><td align="left">AIR</td><td align="left">Lnc2Cancer 3.0</td><td align="left">13</td><td align="left">MIAT</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">14</td><td align="left">GAS5</td><td align="left">Lnc2Cancer 3.0</td><td align="left">14</td><td align="left">DRAIC</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">15</td><td align="left">TUG1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">15</td><td align="left">SRA1</td><td align="left">unconfirmed</td></tr></tbody></table></table-wrap></p>
      <p id="Par41">Prostate cancer is the most common malignancy in male around the world. For identifying a novel bio-labeling for early prediction and treatment in prostate cancer, it is urgently needed that identifying LDAs. We have confirmed 14 of the top-15 candidate lncRNAs to be association with prostate cancer by Lnc2Cancer, LncRNADisease, and published literatures (see Table <xref rid="Tab7" ref-type="table">7</xref>). LncRNA MEG3 has a downregulated in prostate cancer and impact on the abilities of cell proliferation, migration and invasion, and cell apoptosis rate [<xref ref-type="bibr" rid="CR62">62</xref>]. The candidate lncRNA TRAF3IP2-AS1 has no experimental evidence to prove that it is related to prostate cancer.<table-wrap id="Tab7"><label>Table 7</label><caption><p>Top 15 predicted lncRNAs associated with prostate cancer</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="3">Disease similarity based on gene–gene interaction network</th><th align="left" colspan="3">Disease similarity based on disease semantic</th></tr><tr><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">H19</td><td align="left">LncRNADisease v2.0</td><td align="left">1</td><td align="left">TRAF3IP2-AS1</td><td align="left">unconfirmed</td></tr><tr><td align="left">2</td><td align="left">MALAT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">2</td><td align="left">DLX6-AS1</td><td align="left">PMID: 33035382</td></tr><tr><td align="left">3</td><td align="left">TRAF3IP2-AS1</td><td align="left">unconfirmed</td><td align="left">3</td><td align="left">SNHG11</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">4</td><td align="left">PVT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">4</td><td align="left">H19</td><td align="left">LncRNADisease v2.0</td></tr><tr><td align="left">5</td><td align="left">MEG3</td><td align="left">Lnc2Cancer 3.0</td><td align="left">5</td><td align="left">IGF2-AS</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">6</td><td align="left">XIST</td><td align="left">Lnc2Cancer 3.0</td><td align="left">6</td><td align="left">TERC</td><td align="left">LncRNADisease v2.0</td></tr><tr><td align="left">7</td><td align="left">CDKN2B-AS1</td><td align="left">LncRNADisease v2.0</td><td align="left">7</td><td align="left">GAS5</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">8</td><td align="left">UCA1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">8</td><td align="left">MALAT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">9</td><td align="left">KCNQ1OT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">9</td><td align="left">C1QTNF9B-AS1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">10</td><td align="left">GAS5</td><td align="left">Lnc2Cancer 3.0</td><td align="left">10</td><td align="left">MEG3</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">11</td><td align="left">IGF2-AS</td><td align="left">Lnc2Cancer 3.0</td><td align="left">11</td><td align="left">XIST</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">12</td><td align="left">HOTAIR</td><td align="left">Lnc2Cancer 3.0</td><td align="left">12</td><td align="left">PVT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">13</td><td align="left">TUG1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">13</td><td align="left">HOTAIR</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">14</td><td align="left">TERC</td><td align="left">LncRNADisease v2.0</td><td align="left">14</td><td align="left">KCNQ1OT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">15</td><td align="left">CTBP1-AS</td><td align="left">Lnc2Cancer 3.0</td><td align="left">15</td><td align="left">CDKN2B-AS1</td><td align="left">LncRNADisease v2.0</td></tr></tbody></table></table-wrap></p>
      <p id="Par42">Renal cancer is one of the most rapidly growing malignant tumors. Abnormal expression of lncRNAs has been detected in several kinds of renal cancers. It is important to find associations between lncRNAs and renal cancer for cancer prevention, diagnosis, and treatment. The research find that relative level of H19 is significantly higher in clear cell renal carcinoma (ccRCC) compared to the adjacent normal renal tissues. The higher expression of H19 is found in renal cancer cells compared to the nonmalignant renal cells HK-2. So H19 is considered as a potential prognostic indicator and a target for gene therapy of ccRCC [<xref ref-type="bibr" rid="CR63">63</xref>]. In top 15 results, 93% of lncRNAs are verified to be related to renal cancer (see Table <xref rid="Tab8" ref-type="table">8</xref>). For example, KCQN1OT1 and MALAT-1 are the kidney cancer-associated onco-lncRNAs, and H19 and GAS5 are the kidney cancer-associated tumor suppressive lncRNAs [<xref ref-type="bibr" rid="CR64">64</xref>].<table-wrap id="Tab8"><label>Table 8</label><caption><p>Top 15 predicted lncRNAs associated with renal carcinoma</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="3">Disease similarity based on gene–gene interaction network</th><th align="left" colspan="3">Disease similarity based on disease semantic</th></tr><tr><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th><th align="left">Rank</th><th align="left">lncRNA</th><th align="left">Evidence</th></tr></thead><tbody><tr><td align="left">1</td><td align="left">TRAF3IP2-AS1</td><td align="left">PMID: 33741027</td><td align="left">1</td><td align="left">TRAF3IP2-AS1</td><td align="left">PMID: 33741027</td></tr><tr><td align="left">2</td><td align="left">H19</td><td align="left">LncRNADisease v2.0</td><td align="left">2</td><td align="left">DLX6-AS1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">3</td><td align="left">XIST</td><td align="left">Lnc2Cancer 3.0</td><td align="left">3</td><td align="left">SNHG11</td><td align="left">PMID: 32126023</td></tr><tr><td align="left">4</td><td align="left">CDKN2B-AS1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">4</td><td align="left">H19</td><td align="left">LncRNADisease v2.0</td></tr><tr><td align="left">5</td><td align="left">MALAT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">5</td><td align="left">MALAT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">6</td><td align="left">MIAT</td><td align="left">PMID: 30041179</td><td align="left">6</td><td align="left">CDKN2B-AS1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">7</td><td align="left">UCA1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">7</td><td align="left">XIST</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">8</td><td align="left">DRAIC</td><td align="left">LncRNADisease v2.0</td><td align="left">8</td><td align="left">MIAT</td><td align="left">PMID: 30041179</td></tr><tr><td align="left">9</td><td align="left">MIR17HG</td><td align="left">PMID: 24511118</td><td align="left">9</td><td align="left">GAS5</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">10</td><td align="left">MEG3</td><td align="left">Lnc2Cancer 3.0</td><td align="left">10</td><td align="left">MEG3</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">11</td><td align="left">KCNQ1OT1</td><td align="left">LncRNADisease v2.0</td><td align="left">11</td><td align="left">NEAT1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">12</td><td align="left">NEAT1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">12</td><td align="left">KCNQ1OT1</td><td align="left">LncRNADisease v2.0</td></tr><tr><td align="left">13</td><td align="left">TUG1</td><td align="left">Lnc2Cancer 3.0</td><td align="left">13</td><td align="left">UCA1</td><td align="left">Lnc2Cancer 3.0</td></tr><tr><td align="left">14</td><td align="left">PCAT29</td><td align="left">LncRNADisease v2.0</td><td align="left">14</td><td align="left">LSINCT5</td><td align="left">unconfirmed</td></tr><tr><td align="left">15</td><td align="left">MINA</td><td align="left">unconfirmed</td><td align="left">15</td><td align="left">MIR17HG</td><td align="left">PMID: 24511118</td></tr></tbody></table></table-wrap></p>
      <p id="Par43">The experimental results show that the prediction results using the disease similarity based on gene–gene interaction network are more accurate than other results using the disease similarity based on disease semantic.</p>
    </sec>
  </sec>
  <sec id="Sec9">
    <title>Conclusions</title>
    <p id="Par44">Predicting disease-related lncRNAs will help people understand the underlying pathogenesis of diseases. To overcome the time-consuming and expensive shortcomings of experimental methods, researchers have focused on identifying lncRNA-disease potential association by computational methods.</p>
    <p id="Par45">In this paper, we propose an effective LDA prediction method using graph-level graph attention network called gGATLDA. We firstly extract enclosing subgraphs of lncRNA-disease pairs from lncRNA-disease bipartite graph. Next, we compute lncRNA/disease similarity to construct the features of lncRNA/disease nodes in subgraphs. Finally, graph attention network is used to classify lncRNA-disease pairs into true pairs and false pairs according the subgraphs and feature vectors. Three datasets are used to verify the performance of gGATLDA. We compare gGATLDA with several state-of-the-art methods. The experimental results show that our method gGATLDA can achieve higher values of AUC and AUPR. Furthermore, case study also show that our method can accurately predict LDAs. In the future, we will further improve the prediction performance of gGATLDA by the following aspects. Firstly, we will study better selecting negative sample method to avoid false negative caused by random selection. Secondly, lncRNA similarity and disease similarity are important to improve the prediction performance. At present, most models only use lncRNA-disease functional similarity based on lncRNA-disease interaction. In addition, there are lncRNA/disease similarities based on other different biological data sources, such as lncRNA expression based functional similarity, GO term based lncRNA functional similarity, lncRNA-disease association based functional similarity and miRNA/mRNA-lncRNA interaction based functional similarity. Each similarity has its own strengths and weaknesses [<xref ref-type="bibr" rid="CR65">65</xref>]. We will study methods for integrating different functional similarities. Lastly, we will extend our method to predict potential interaction relationship in other biologic interaction networks.</p>
    <p id="Par46">Moreover, the advancement of miRNA-disease association prediction can provide valuable reference for LDAs prediction. For example, Chen et al. [<xref ref-type="bibr" rid="CR66">66</xref>] presented a model of inductive matrix completion for miRNA-disease association prediction. This method based on matrix completion had been successfully applied to LDA prediction [<xref ref-type="bibr" rid="CR48">48</xref>]. However, the miRNA-disease prediction methods based on matrix decomposition and heterogeneous graph inference had been not used to LDA prediction [<xref ref-type="bibr" rid="CR67">67</xref>]. Therefore, we will study how can more accurate predict lncRNA-disease potential associations in the future work by referencing some important computational models in literate [<xref ref-type="bibr" rid="CR68">68</xref>].</p>
  </sec>
  <sec id="Sec10">
    <title>Datasets and methods</title>
    <sec id="Sec11">
      <title>Datasets</title>
      <p id="Par47">In order to experimentally verify the advantages of the method gGATLDA, we use two benchmark lncRNA-disease datasets: one dataset contains fewer known LDAs and another dataset contains more known LDAs. We download the Dataset1 from the lncRNADisease established in 2015, which includes 621 associations between 256 lncRNAs and 189 diseases. The Dataset2 in literate [<xref ref-type="bibr" rid="CR47">47</xref>] is downloaded from <ext-link ext-link-type="uri" xlink:href="http://mlda.swu.edu.cn/codes.php?name=MFLDA">http://mlda.swu.edu.cn/codes.php?name=MFLDA</ext-link>, which includes 2697 associations between 240 lncRNAs and 412 diseases. Dataset density represents the proportion of known associations among all in the dataset. The density of Dataset1 and Dataset2 are 0.96% and 2.73% respectively. We obtain Dataset3 by merging the two datasets Dataset1 and Dataset2. The overlap of Dataset1 and Dataset2 are shown in Fig. <xref rid="Fig6" ref-type="fig">6</xref>. We remove all repeated lncRNAs and diseases in Dataset1 and Dataset2. Finally, we obtain 3207 known associations between 443 lncRNAs and 608 diseases. The three benchmark datasets are shown in Table <xref rid="Tab9" ref-type="table">9</xref>.<fig id="Fig6"><label>Fig. 6</label><caption><p>Venn diagrams of the two datasets</p></caption><graphic xlink:href="12859_2021_4548_Fig6_HTML" id="MO6"/></fig><table-wrap id="Tab9"><label>Table 9</label><caption><p>Three benchmark datasets</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Datasets</th><th align="left">lncRNAs</th><th align="left">Diseases</th><th align="left">Associations</th></tr></thead><tbody><tr><td align="left">Dataset1</td><td align="left">285</td><td align="left">226</td><td align="left">621</td></tr><tr><td align="left">Dataset2</td><td align="left">240</td><td align="left">412</td><td align="left">2697</td></tr><tr><td align="left">Dataset3</td><td align="left">443</td><td align="left">608</td><td align="left">3207</td></tr></tbody></table></table-wrap></p>
      <p id="Par48">We construct an adjacency matrix <inline-formula id="IEq1"><alternatives><tex-math id="M97">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$A\in {\mathbb{R}}^{L\times D}$$\end{document}</tex-math><mml:math id="M98"><mml:mrow><mml:mi>A</mml:mi><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mo>×</mml:mo><mml:mi>D</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq1.gif"/></alternatives></inline-formula> to represent the association pairs between <italic>L</italic> lncRNAs and <italic>D</italic> diseases, where <inline-formula id="IEq2"><alternatives><tex-math id="M99">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$A\left(l,d\right)=1$$\end{document}</tex-math><mml:math id="M100"><mml:mrow><mml:mi>A</mml:mi><mml:mfenced close=")" open="("><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>d</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq2.gif"/></alternatives></inline-formula> if there is an experimentally verified association between lncRNA <inline-formula id="IEq3"><alternatives><tex-math id="M101">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$l$$\end{document}</tex-math><mml:math id="M102"><mml:mi>l</mml:mi></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq3.gif"/></alternatives></inline-formula> and disease <inline-formula id="IEq4"><alternatives><tex-math id="M103">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d$$\end{document}</tex-math><mml:math id="M104"><mml:mi>d</mml:mi></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq4.gif"/></alternatives></inline-formula>, otherwise <inline-formula id="IEq5"><alternatives><tex-math id="M105">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$A\left(l,d\right)=0$$\end{document}</tex-math><mml:math id="M106"><mml:mrow><mml:mi>A</mml:mi><mml:mfenced close=")" open="("><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>d</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq5.gif"/></alternatives></inline-formula>.<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M107">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$A\left(l,d\right)=\left\{ \begin{array}{c}1, if\ lncRNA\ l\ associated\ with\ disease\ d \\ 0, otherwise\end{array}\right.$$\end{document}</tex-math><mml:math id="M108" display="block"><mml:mrow><mml:mi>A</mml:mi><mml:mfenced close=")" open="("><mml:mi>l</mml:mi><mml:mo>,</mml:mo><mml:mi>d</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced open="{"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="4pt"/><mml:mi>l</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>R</mml:mi><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mspace width="4pt"/><mml:mi>l</mml:mi><mml:mspace width="4pt"/><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>s</mml:mi><mml:mi>o</mml:mi><mml:mi>c</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi><mml:mspace width="4pt"/><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mspace width="4pt"/><mml:mi>d</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mi>a</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi><mml:mspace width="4pt"/><mml:mi>d</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p>
    </sec>
    <sec id="Sec12">
      <title>Gaussian interaction profile kernel similarity of lncRNAs</title>
      <p id="Par49">Gaussian kernel function has been used to effectively measure lncRNA similarity [<xref ref-type="bibr" rid="CR48">48</xref>]. Let the lncRNA similarity matrix be <inline-formula id="IEq6"><alternatives><tex-math id="M109">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{lnc}\in {\mathbb{R}}^{L\times L}$$\end{document}</tex-math><mml:math id="M110"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">lnc</mml:mi></mml:mrow></mml:msub><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mo>×</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq6.gif"/></alternatives></inline-formula>. The Gaussian interaction profile kernel similarity <inline-formula id="IEq7"><alternatives><tex-math id="M111">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{lnc}\left({l}_{i},{l}_{j}\right)$$\end{document}</tex-math><mml:math id="M112"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">lnc</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq7.gif"/></alternatives></inline-formula> between lncRNA <inline-formula id="IEq8"><alternatives><tex-math id="M113">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${l}_{i}$$\end{document}</tex-math><mml:math id="M114"><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq8.gif"/></alternatives></inline-formula> and <inline-formula id="IEq9"><alternatives><tex-math id="M115">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${l}_{j}$$\end{document}</tex-math><mml:math id="M116"><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq9.gif"/></alternatives></inline-formula> can be calculated as follows:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M117">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{lnc}\left({l}_{i},{l}_{j}\right)=\mathrm{exp}\left(-{\beta }_{l}{\Vert IP\left({l}_{i}\right)-IP\left({l}_{j}\right)\Vert }^{2}\right)$$\end{document}</tex-math><mml:math id="M118" display="block"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">lnc</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mi mathvariant="normal">exp</mml:mi><mml:mfenced close=")" open="("><mml:mo>-</mml:mo><mml:msub><mml:mi>β</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy="false">‖</mml:mo><mml:mi>I</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mfenced close=")" open="("><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>-</mml:mo><mml:mi>I</mml:mi><mml:mi>P</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>l</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mrow><mml:mo stretchy="false">‖</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msup></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>where the <italic>i</italic>th row <inline-formula id="IEq10"><alternatives><tex-math id="M119">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$IP({l}_{i})$$\end{document}</tex-math><mml:math id="M120"><mml:mrow><mml:mi>I</mml:mi><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq10.gif"/></alternatives></inline-formula> of the lncRNA-disease association matrix is a binary vector, which represents whether lncRNA <inline-formula id="IEq11"><alternatives><tex-math id="M121">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${l}_{i}$$\end{document}</tex-math><mml:math id="M122"><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq11.gif"/></alternatives></inline-formula> is associated with each disease, <italic>i</italic> = 1, 2 , … , <italic>L</italic>. The normalized bandwidth <inline-formula id="IEq12"><alternatives><tex-math id="M123">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\beta }_{l}$$\end{document}</tex-math><mml:math id="M124"><mml:msub><mml:mi>β</mml:mi><mml:mi>l</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq12.gif"/></alternatives></inline-formula> is calculated by the average number of diseases associated with each lncRNA, its formula are as follows:<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M125">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\beta }_{l}=\frac{1}{L}\sum_{i=1}^{L}{\Vert IP\left({l}_{i}\right)\Vert }^{2})$$\end{document}</tex-math><mml:math id="M126" display="block"><mml:mrow><mml:msub><mml:mi>β</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>L</mml:mi></mml:mfrac><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>L</mml:mi></mml:munderover><mml:msup><mml:mrow><mml:mrow><mml:mo stretchy="false">‖</mml:mo><mml:mi>I</mml:mi><mml:mi>P</mml:mi></mml:mrow><mml:mfenced close=")" open="("><mml:msub><mml:mi>l</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mrow><mml:mo stretchy="false">‖</mml:mo></mml:mrow></mml:mrow><mml:mn>2</mml:mn></mml:msup><mml:mrow><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula></p>
    </sec>
    <sec id="Sec13">
      <title>Disease similarity computation based on gene–gene interaction network</title>
      <p id="Par50">The network distance between two disease modules indicates their pathobiological and clinical similarity. If two disease modules are topologically separated in the network, they are considered as pathobiologically distinct. If two disease modules are topologically overlapped, the magnitude of the overlap is indicative of their biological relationship. The higher the overlap degree, the more significant pathobiological similarity between the two disease modules [<xref ref-type="bibr" rid="CR69">69</xref>]. We propose a new disease similarity computation based on gene–gene interaction network. We define a set of all genes related to a disease as a disease module, and measure the disease similarity by distance between two disease modules in the gene interaction network. The shorter their distance, the more similar the two diseases. The calculation of disease similarity based on gene–gene interaction network are mainly described as follows:</p>
      <p id="Par51">(1)We download the two datasets, one is disease-gene associations from the database DisGeNET at <ext-link ext-link-type="uri" xlink:href="https://www.disgenet.org/">https://www.disgenet.org/</ext-link> [<xref ref-type="bibr" rid="CR70">70</xref>] and another one is gene–gene interaction network at <ext-link ext-link-type="uri" xlink:href="https://science.sciencemag.org/content/suppl/2015/02/18/347.6224.1257601.DC1">https://science.sciencemag.org/content/suppl/2015/02/18/347.6224.1257601.DC1</ext-link> [<xref ref-type="bibr" rid="CR69">69</xref>]. We unify the name of diseases of synonymous but different terms in the disease-gene database, and retain the disease-gene association data of those diseases in the benchmark dataset.</p>
      <p id="Par52">(2)For any two diseases, we solve the gene sets associating with diseases <inline-formula id="IEq13"><alternatives><tex-math id="M127">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{i}$$\end{document}</tex-math><mml:math id="M128"><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq13.gif"/></alternatives></inline-formula> and <inline-formula id="IEq14"><alternatives><tex-math id="M129">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{j}$$\end{document}</tex-math><mml:math id="M130"><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq14.gif"/></alternatives></inline-formula> respectively according to the disease-gene association network. Let the gene set related to disease <inline-formula id="IEq15"><alternatives><tex-math id="M131">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{i}$$\end{document}</tex-math><mml:math id="M132"><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq15.gif"/></alternatives></inline-formula> be <italic>A</italic> and the gene set related to disease <inline-formula id="IEq16"><alternatives><tex-math id="M133">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{j}$$\end{document}</tex-math><mml:math id="M134"><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq16.gif"/></alternatives></inline-formula> be <italic>B</italic>, the mean shortest distance <inline-formula id="IEq17"><alternatives><tex-math id="M135">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{AB}$$\end{document}</tex-math><mml:math id="M136"><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">AB</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq17.gif"/></alternatives></inline-formula> between gene sets <italic>A</italic> and <italic>B</italic> is calculated as follows:<disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M137">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{AB}={d}_{AB}-\frac{({d}_{AA}+{d}_{BB})}{2}$$\end{document}</tex-math><mml:math id="M138" display="block"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">AB</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant="italic">AB</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant="italic">AA</mml:mi></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant="italic">BB</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mn>2</mml:mn></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq18"><alternatives><tex-math id="M139">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{AA}$$\end{document}</tex-math><mml:math id="M140"><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant="italic">AA</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq18.gif"/></alternatives></inline-formula> is the mean shortest distance of distances among all gene–gene pairs in gene set <italic>A</italic>, <inline-formula id="IEq19"><alternatives><tex-math id="M141">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{BB}$$\end{document}</tex-math><mml:math id="M142"><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant="italic">BB</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq19.gif"/></alternatives></inline-formula> is the mean shortest distance of distances among all gene–gene pairs in gene set <italic>B</italic>, and <inline-formula id="IEq20"><alternatives><tex-math id="M143">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{AB}$$\end{document}</tex-math><mml:math id="M144"><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi mathvariant="italic">AB</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq20.gif"/></alternatives></inline-formula> is the mean shortest one of distances between gene sets <italic>A</italic> and <italic>B</italic>.</p>
      <p id="Par53">(3) The larger the <italic>S</italic><sub><italic>AB</italic></sub>, the greater separation between the two gene sets <italic>A</italic> and <italic>B</italic> associated with disease <inline-formula id="IEq21"><alternatives><tex-math id="M145">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{i}$$\end{document}</tex-math><mml:math id="M146"><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq21.gif"/></alternatives></inline-formula> and disease <inline-formula id="IEq22"><alternatives><tex-math id="M147">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{j}$$\end{document}</tex-math><mml:math id="M148"><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq22.gif"/></alternatives></inline-formula> respectively, which means the higher similarity between diseases <inline-formula id="IEq23"><alternatives><tex-math id="M149">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{i}$$\end{document}</tex-math><mml:math id="M150"><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq23.gif"/></alternatives></inline-formula> and <inline-formula id="IEq24"><alternatives><tex-math id="M151">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{j}$$\end{document}</tex-math><mml:math id="M152"><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq24.gif"/></alternatives></inline-formula>. On the other hand, the smaller the <italic>S</italic><sub><italic>AB</italic></sub>, the larger overlap between the two gene sets <italic>A</italic> and <italic>B</italic> associated with disease <inline-formula id="IEq25"><alternatives><tex-math id="M153">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{i}$$\end{document}</tex-math><mml:math id="M154"><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq25.gif"/></alternatives></inline-formula> and disease <inline-formula id="IEq26"><alternatives><tex-math id="M155">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{j}$$\end{document}</tex-math><mml:math id="M156"><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq26.gif"/></alternatives></inline-formula> respectively, which means the lower similarity between diseases <inline-formula id="IEq27"><alternatives><tex-math id="M157">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{i}$$\end{document}</tex-math><mml:math id="M158"><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq27.gif"/></alternatives></inline-formula> and <inline-formula id="IEq28"><alternatives><tex-math id="M159">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{j}$$\end{document}</tex-math><mml:math id="M160"><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq28.gif"/></alternatives></inline-formula>. The similarity <inline-formula id="IEq29"><alternatives><tex-math id="M161">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{dis}\left({d}_{i},{d}_{j}\right)$$\end{document}</tex-math><mml:math id="M162"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">dis</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq29.gif"/></alternatives></inline-formula> between diseases <inline-formula id="IEq30"><alternatives><tex-math id="M163">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{i}$$\end{document}</tex-math><mml:math id="M164"><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq30.gif"/></alternatives></inline-formula> and <inline-formula id="IEq31"><alternatives><tex-math id="M165">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${d}_{j}$$\end{document}</tex-math><mml:math id="M166"><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq31.gif"/></alternatives></inline-formula> based on gene–gene interaction network is calculated as follows:<disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M167">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{dis}\left({d}_{i},{d}_{j}\right)=1-\frac{{S}_{AB}-\mathrm{min}\left({S}_{AB}\right)}{\mathrm{max}\left({S}_{AB}\right)}$$\end{document}</tex-math><mml:math id="M168" display="block"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">dis</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>d</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>d</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">AB</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:mi mathvariant="normal">min</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">AB</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant="normal">max</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">AB</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula></p>
    </sec>
  </sec>
  <sec id="Sec14">
    <title>Methods</title>
    <p id="Par54">In this paper, we propose a new lncRNA-disease association prediction method based on graph-level graph attention network called gGATLDA. As illustrated in Fig. <xref rid="Fig7" ref-type="fig">7</xref>, the gGATLDA consists of the following three major steps. Firstly, the enclosing subgraphs of lncRNA-disease pairs are extracted according to lncRNA-disease bipartite graph. Secondly, feature vectors of lncRNA-disease pairs are constructed according to Gaussian interaction profile kernel lncRNA similarities and gene interaction network-based disease similarities. Finally, the subgraphs and feature vectors of the lncRNA-disease pairs are used as the inputs to train the graph attention network model, a probability score of each lncRNA-disease pair is obtained, and the potential LDAs are predicted by ranking these probability scores.<fig id="Fig7"><label>Fig. 7</label><caption><p>Procedure of the method gGATLDA</p></caption><graphic xlink:href="12859_2021_4548_Fig7_HTML" id="MO7"/></fig></p>
    <sec id="Sec15">
      <title>Extracting the enclosing subgraphs</title>
      <p id="Par55">For the known LDAs matrix <italic>A</italic>, its corresponding bipartite graph <italic>G</italic> can be constructed. If there is an association between lncRNA <italic>l</italic> and disease <italic>d</italic>, there is an edge between nodes <italic>l</italic> and <italic>d</italic> in <italic>G</italic>, otherwise there is no an edge between nodes <italic>l</italic> and <italic>d</italic>. The <italic>h</italic>-hop enclosing subgraph <italic>G</italic><sub>1</sub>(<italic>V</italic><sub>1</sub>,<italic>E</italic><sub>1</sub>) of each lncRNA-disease pair (<italic>l,d</italic>) is defined as the following: <italic>V</italic><sub>1</sub> is node set including nodes <italic>l</italic> and <italic>d</italic>, as well as their <italic>h</italic>-hop neighbor nodes, <inline-formula id="IEq32"><alternatives><tex-math id="M169">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${E}_{1}$$\end{document}</tex-math><mml:math id="M170"><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq32.gif"/></alternatives></inline-formula> is edge set, <inline-formula id="IEq33"><alternatives><tex-math id="M171">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\forall (u,v)\in {E}_{1}$$\end{document}</tex-math><mml:math id="M172"><mml:mrow><mml:mo>∀</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>u</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>∈</mml:mo><mml:msub><mml:mi>E</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq33.gif"/></alternatives></inline-formula>, there must be <inline-formula id="IEq34"><alternatives><tex-math id="M173">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$u,v\in {V}_{1}$$\end{document}</tex-math><mml:math id="M174"><mml:mrow><mml:mi>u</mml:mi><mml:mo>,</mml:mo><mml:mi>v</mml:mi><mml:mo>∈</mml:mo><mml:msub><mml:mi>V</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq34.gif"/></alternatives></inline-formula>.</p>
      <p id="Par56">The previous LDAs prediction method based on GNN used node embedding as input to GNN. Considering that local subgraphs can contain richer graph patterns, we extract the <italic>h</italic>-hop enclosing subgraphs of each lncRNA-disease node pair, and use them as the input to train GAT-based model for improving prediction performance.</p>
    </sec>
    <sec id="Sec16">
      <title>Node labeling</title>
      <p id="Par57">Each node in the subgraph can be labeled to distinguish its role [<xref ref-type="bibr" rid="CR71">71</xref>]. We use 0 and 1 to label the target lncRNA node and target disease node respectively. For other nodes in subgraph, if it is an lncRNA-type node, we will label it as 2<italic>i</italic>; if it is a disease-type node, we will label it as 2<italic>i</italic> + 1, where <italic>i</italic> is a number in the <italic>i-</italic>th hop neighbor of the target node.</p>
    </sec>
    <sec id="Sec17">
      <title>Constructing feature vectors for lncRNAs/diseases</title>
      <p id="Par58">The feature vector for each lncRNA node is constructed based on lncRNA similarity, and the feature vector for each disease node is constructed based on disease similarity. The feature vectors are used as node attribute of subgraph. Let lncRNA similarity matrix be <inline-formula id="IEq35"><alternatives><tex-math id="M175">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{lnc}\in {\mathbb{R}}^{L\times L}$$\end{document}</tex-math><mml:math id="M176"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">lnc</mml:mi></mml:mrow></mml:msub><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mo>×</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq35.gif"/></alternatives></inline-formula> and disease similarity matrix be <inline-formula id="IEq36"><alternatives><tex-math id="M177">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{dis}\in {\mathbb{R}}^{D\times D}$$\end{document}</tex-math><mml:math id="M178"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">dis</mml:mi></mml:mrow></mml:msub><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mo>×</mml:mo><mml:mi>D</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq36.gif"/></alternatives></inline-formula>, where <italic>L</italic> and <italic>D</italic> is the number of lncRNAs and diseases respectively, we construct the lncRNA feature matrix <inline-formula id="IEq37"><alternatives><tex-math id="M179">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${F}_{lnc}\in {\mathbb{R}}^{L\times \left(L+D+K\right)}$$\end{document}</tex-math><mml:math id="M180"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi mathvariant="italic">lnc</mml:mi></mml:mrow></mml:msub><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:mrow><mml:mi>L</mml:mi><mml:mo>×</mml:mo><mml:mfenced close=")" open="("><mml:mi>L</mml:mi><mml:mo>+</mml:mo><mml:mi>D</mml:mi><mml:mo>+</mml:mo><mml:mi>K</mml:mi></mml:mfenced></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq37.gif"/></alternatives></inline-formula> and the disease feature matrix <inline-formula id="IEq38"><alternatives><tex-math id="M181">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${F}_{dis}\in {\mathbb{R}}^{D\times (L+D+K)}$$\end{document}</tex-math><mml:math id="M182"><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi mathvariant="italic">dis</mml:mi></mml:mrow></mml:msub><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mo>×</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>L</mml:mi><mml:mo>+</mml:mo><mml:mi>D</mml:mi><mml:mo>+</mml:mo><mml:mi>K</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq38.gif"/></alternatives></inline-formula>. In order to make the feature vector dimension of lncRNA the same as that of disease, the feature vector of lncRNA <italic>l</italic> is <inline-formula id="IEq39"><alternatives><tex-math id="M183">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${f}_{l}=\{{f}_{l1},{f}_{l2},{f}_{l3},\dots ,{f}_{{l}_{m}}, 0, 0,\dots ,0,{b}_{1},{b}_{2},\dots ,{b}_{K}\}$$\end{document}</tex-math><mml:math id="M184"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>l</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">{</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>l</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:msub><mml:mi>l</mml:mi><mml:mi>m</mml:mi></mml:msub></mml:msub><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mi>K</mml:mi></mml:msub><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq39.gif"/></alternatives></inline-formula>, and the feature vector of disease <italic>d</italic> is <inline-formula id="IEq40"><alternatives><tex-math id="M185">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${f}_{d}=\{0, 0,\dots ,0,{f}_{d1},{f}_{d2},{f}_{d3},\dots ,{f}_{{d}_{n}},{b}_{1},{b}_{2},\dots ,{b}_{K}\}$$\end{document}</tex-math><mml:math id="M186"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mi>d</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mrow><mml:mo stretchy="false">{</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mn>3</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:msub><mml:mi>d</mml:mi><mml:mi>n</mml:mi></mml:msub></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mi>K</mml:mi></mml:msub><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq40.gif"/></alternatives></inline-formula>, where <inline-formula id="IEq41"><alternatives><tex-math id="M187">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$1\le m\le L$$\end{document}</tex-math><mml:math id="M188"><mml:mrow><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mi>m</mml:mi><mml:mo>≤</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq41.gif"/></alternatives></inline-formula>, <inline-formula id="IEq42"><alternatives><tex-math id="M189">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$1\le n\le D$$\end{document}</tex-math><mml:math id="M190"><mml:mrow><mml:mn>1</mml:mn><mml:mo>≤</mml:mo><mml:mi>n</mml:mi><mml:mo>≤</mml:mo><mml:mi>D</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq42.gif"/></alternatives></inline-formula>, <italic>b</italic><sub><italic>j</italic></sub> is the <italic>k</italic>-bit one-hot code of the node label, <italic>j</italic> = 1,2,…,<italic>K</italic>.</p>
    </sec>
    <sec id="Sec18">
      <title>The model based on graph neural network</title>
      <p id="Par59">We employ a stacked graph neural network layers as the classifier for predicting LDAs. The <italic>h</italic>-hop enclosing subgraph <italic>G</italic><sub>1</sub> for lncRNA <italic>l</italic> and disease <italic>d</italic> and feature vectors of each node in <italic>G</italic><sub>1</sub> are fed into prediction model. The model is trained to obtain prediction score between lncRNA <italic>l</italic> and disease <italic>d</italic>.</p>
      <p id="Par60">As shown in Fig. <xref rid="Fig7" ref-type="fig">7</xref>, our model includes a single graph convolutional network  (GCN) layer and multilayer graph attention network (GAT) layer. Here, we first leverage GCN to learn graph patterns by aggregating representations of their neighborhood nodes to obtain lncRNA/disease latent features. The first layer, i.e., the GCN layer, is formulated as follows:<disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M191">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${x}_{i}^{1}=\sum_{j\in \mathcal{N}\left(i\right)\cup \{i\}}\frac{1}{\sqrt{\mathrm{deg}\left(i\right)}\bullet \sqrt{\mathrm{deg}\left(j\right)}}({W}^{1}{x}_{j}^{0})$$\end{document}</tex-math><mml:math id="M192" display="block"><mml:mrow><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msubsup><mml:mo>=</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:mi mathvariant="script">N</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced><mml:mo>∪</mml:mo><mml:mrow><mml:mo stretchy="false">{</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">}</mml:mo></mml:mrow></mml:mrow></mml:munder><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msqrt><mml:mrow><mml:mi mathvariant="normal">deg</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced></mml:mrow></mml:msqrt><mml:mo>∙</mml:mo><mml:msqrt><mml:mrow><mml:mi mathvariant="normal">deg</mml:mi><mml:mfenced close=")" open="("><mml:mi>j</mml:mi></mml:mfenced></mml:mrow></mml:msqrt></mml:mrow></mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msup><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq43"><alternatives><tex-math id="M193">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${x}_{j}^{0}$$\end{document}</tex-math><mml:math id="M194"><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mn>0</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq43.gif"/></alternatives></inline-formula> denotes the feature vector of node <italic>j</italic> in layer 0 (input layer), <inline-formula id="IEq44"><alternatives><tex-math id="M195">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal{N}\left(i\right)$$\end{document}</tex-math><mml:math id="M196"><mml:mrow><mml:mi mathvariant="script">N</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq44.gif"/></alternatives></inline-formula> denotes the set of all neighbor nodes of node <italic>i</italic>, <inline-formula id="IEq45"><alternatives><tex-math id="M197">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathrm{deg}\left(i\right)$$\end{document}</tex-math><mml:math id="M198"><mml:mrow><mml:mi mathvariant="normal">deg</mml:mi><mml:mfenced close=")" open="("><mml:mi>i</mml:mi></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq45.gif"/></alternatives></inline-formula> denotes the degree of node <italic>i</italic>, and <inline-formula id="IEq46"><alternatives><tex-math id="M199">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${W}^{1}$$\end{document}</tex-math><mml:math id="M200"><mml:msup><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mn>1</mml:mn></mml:msup></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq46.gif"/></alternatives></inline-formula> denotes the parameter matrix to be learned of the GCN layer.</p>
      <p id="Par61">Most of the GNNs use a messaging-passing scheme in which the embedding of a node is iteratively updated by aggregating the information from its neighbors [<xref ref-type="bibr" rid="CR72">72</xref>]. To assign learnable weights in the aggregation, GNNs incorporate the attention mechanism. When aggregating neighbor embedding, the characteristics of neighbor nodes are weighted by attention coefficients between current node and its neighbors, such that GNNs can pay more attention to important nodes to reduce the impact of edge noise. Therefore, after the first GCN layer, we stack multi-layer graph attention layer. The output feature <inline-formula id="IEq47"><alternatives><tex-math id="M201">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{i}^{(l+1)}$$\end{document}</tex-math><mml:math id="M202"><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>l</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq47.gif"/></alternatives></inline-formula> of the <italic>l</italic> + 1th layer is calculated as follows:<disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M203">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${e}_{ij}^{l}=a(W{h}_{i}^{\left(l\right)},W{h}_{j}^{(l)})$$\end{document}</tex-math><mml:math id="M204" display="block"><mml:mrow><mml:msubsup><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:mi>a</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>W</mml:mi><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mfenced close=")" open="("><mml:mi>l</mml:mi></mml:mfenced></mml:msubsup><mml:mo>,</mml:mo><mml:mi>W</mml:mi><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>l</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M205">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\alpha }_{ij}^{l}={softmax}_{i}({e}_{ij}^{l})$$\end{document}</tex-math><mml:math id="M206" display="block"><mml:mrow><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="italic">softmax</mml:mi></mml:mrow><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msubsup><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ9"><label>9</label><alternatives><tex-math id="M207">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{i}^{(l+1)}=\upsigma (\sum_{j\in \mathcal{N}(i)}{\alpha }_{ij}{W}^{(l)}{h}_{j}^{(l)})$$\end{document}</tex-math><mml:math id="M208" display="block"><mml:mrow><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>l</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo>=</mml:mo><mml:mi mathvariant="normal">σ</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:munder><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>∈</mml:mo><mml:mi mathvariant="script">N</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>i</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:munder><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:msup><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>l</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>l</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq48"><alternatives><tex-math id="M209">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a$$\end{document}</tex-math><mml:math id="M210"><mml:mi>a</mml:mi></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq48.gif"/></alternatives></inline-formula> is a function for calculating the correlation between two nodes, <inline-formula id="IEq49"><alternatives><tex-math id="M211">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${e}_{ij }^{l}$$\end{document}</tex-math><mml:math id="M212"><mml:msubsup><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq49.gif"/></alternatives></inline-formula> is the original attention coefficient between node <italic>i</italic> and node <italic>j</italic> in the <italic>l</italic>-th layer, <inline-formula id="IEq50"><alternatives><tex-math id="M213">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\alpha }_{ij}^{l}$$\end{document}</tex-math><mml:math id="M214"><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow><mml:mi>l</mml:mi></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq50.gif"/></alternatives></inline-formula> is the attention weight by softmax function, <inline-formula id="IEq51"><alternatives><tex-math id="M215">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{i}^{(l+1)}$$\end{document}</tex-math><mml:math id="M216"><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>l</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq51.gif"/></alternatives></inline-formula> is the representation of node <italic>i</italic> in the <italic>l</italic> + 1-th layer, <inline-formula id="IEq52"><alternatives><tex-math id="M217">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\upsigma$$\end{document}</tex-math><mml:math id="M218"><mml:mi mathvariant="normal">σ</mml:mi></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq52.gif"/></alternatives></inline-formula> denotes the non-liner activation function. Here we choose ELU as activation function.</p>
      <p id="Par62">For the output of the <italic>L</italic>th GAT layer, we concatenate the final representations of the target lncRNA and disease as graph representation <inline-formula id="IEq53"><alternatives><tex-math id="M219">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${g}_{i}$$\end{document}</tex-math><mml:math id="M220"><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq53.gif"/></alternatives></inline-formula>:<disp-formula id="Equ10"><label>10</label><alternatives><tex-math id="M221">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${g}_{i}=\mathrm{concat}({h}_{lnc},{h}_{dis})$$\end{document}</tex-math><mml:math id="M222" display="block"><mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">concat</mml:mi><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi mathvariant="italic">lnc</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi mathvariant="italic">dis</mml:mi></mml:mrow></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ10.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par63">Finally, for the graph representation <inline-formula id="IEq54"><alternatives><tex-math id="M223">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${g}_{i}$$\end{document}</tex-math><mml:math id="M224"><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq54.gif"/></alternatives></inline-formula>, we use Softmax function to obtain the prediction likelihood <inline-formula id="IEq55"><alternatives><tex-math id="M225">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${y}_{i}^{^{\prime}}$$\end{document}</tex-math><mml:math id="M226"><mml:msubsup><mml:mi>y</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:msup><mml:mrow/><mml:mo>′</mml:mo></mml:msup></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq55.gif"/></alternatives></inline-formula>:<disp-formula id="Equ11"><label>11</label><alternatives><tex-math id="M227">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${y}_{i}^{^{\prime}}=\mathrm{softmax}\left({g}_{i}\right)=\frac{{e}^{{g}_{i}}}{{\sum }_{j=1}^{n}{e}^{{g}_{i}}},i=\mathrm{1,2},\dots ,n$$\end{document}</tex-math><mml:math id="M228" display="block"><mml:mrow><mml:msubsup><mml:mi>y</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:msup><mml:mrow/><mml:mo>′</mml:mo></mml:msup></mml:msubsup><mml:mo>=</mml:mo><mml:mi mathvariant="normal">softmax</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mfrac><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msup><mml:mrow><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup><mml:msup><mml:mrow><mml:mi>e</mml:mi></mml:mrow><mml:msub><mml:mi>g</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msup></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn></mml:mrow><mml:mo>,</mml:mo><mml:mo>⋯</mml:mo><mml:mo>,</mml:mo><mml:mi>n</mml:mi></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ11.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par64">The weights <inline-formula id="IEq56"><alternatives><tex-math id="M229">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${W}^{(l)}$$\end{document}</tex-math><mml:math id="M230"><mml:msup><mml:mrow><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>l</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msup></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq56.gif"/></alternatives></inline-formula> are trained to minimize the loss function:<disp-formula id="Equ12"><label>12</label><alternatives><tex-math id="M231">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\mathcal{L}=-\sum_{k=1}^{N}({y}_{i}*log{y}_{i}^{^{\prime}})$$\end{document}</tex-math><mml:math id="M232" display="block"><mml:mrow><mml:mi mathvariant="script">L</mml:mi><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>k</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>N</mml:mi></mml:munderover><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow/><mml:mo>∗</mml:mo><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>g</mml:mi><mml:msubsup><mml:mi>y</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:msup><mml:mrow/><mml:mo>′</mml:mo></mml:msup></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><graphic xlink:href="12859_2021_4548_Article_Equ12.gif" position="anchor"/></alternatives></disp-formula>where <inline-formula id="IEq57"><alternatives><tex-math id="M233">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${y}_{i}$$\end{document}</tex-math><mml:math id="M234"><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq57.gif"/></alternatives></inline-formula> represents the real value, <inline-formula id="IEq58"><alternatives><tex-math id="M235">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${y}_{i}^{^{\prime}}$$\end{document}</tex-math><mml:math id="M236"><mml:msubsup><mml:mi>y</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:msup><mml:mrow/><mml:mo>′</mml:mo></mml:msup></mml:msubsup></mml:math><inline-graphic xlink:href="12859_2021_4548_Article_IEq58.gif"/></alternatives></inline-formula> is the predicted value.</p>
      <p id="Par65">Based on the above work, we presented a graph-level graph attention network based LDA prediction algorithm called gGATLDA.<graphic position="anchor" xlink:href="12859_2021_4548_Figa_HTML" id="MO8"/></p>
    </sec>
  </sec>
</body>
<back>
  <glossary>
    <title>Abbreviations</title>
    <def-list>
      <def-item>
        <term>gGATLDA</term>
        <def>
          <p id="Par4">LncRNA-disease association prediction method based on graph-level graph attention network</p>
        </def>
      </def-item>
      <def-item>
        <term>GCN</term>
        <def>
          <p id="Par5">Graph convolutional network</p>
        </def>
      </def-item>
      <def-item>
        <term>GAT</term>
        <def>
          <p id="Par6">Graph attention network</p>
        </def>
      </def-item>
      <def-item>
        <term>ROC</term>
        <def>
          <p id="Par7">Receiver operating characteristic</p>
        </def>
      </def-item>
      <def-item>
        <term>AUC</term>
        <def>
          <p id="Par8">Areas under ROC curve</p>
        </def>
      </def-item>
      <def-item>
        <term>AUPR</term>
        <def>
          <p id="Par9">Areas under precision-recall curve</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>The authors thank the editor and anonymous reviewers for their constructive comments and suggestions, which greatly help us improve our manuscript. This experimental work is supported by the high-performance computing center of Guangxi University.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors' contributions</title>
    <p>LW and CZ designed the methodology. LW developed and implemented the method. LW and CZ performed the experiments and analyzed the results. LW and CZ wrote and revised the manuscript. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This work is supported by the National Natural Science Foundation of China under Grant Nos. 61962004 and 61462005.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>All the data used are collected from the public datasets below. The Dataset1can be downloaded from the lncRNADisease established in 2015 (<ext-link ext-link-type="uri" xlink:href="http://www.cuilab.cn/lncrnadisease">http://www.cuilab.cn/lncrnadisease</ext-link>). The Dataset2 can be downloaded from <ext-link ext-link-type="uri" xlink:href="http://mlda.swu.edu.cn/codes.php?name=MFLDA">http://mlda.swu.edu.cn/codes.php?name=MFLDA</ext-link>. The source code is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/LiWangG/gGATLDA">https://github.com/LiWangG/gGATLDA</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par66">Not applicable.</p>
    </notes>
    <notes id="FPar2" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par67">The authors declare that they have no competing interests.</p>
    </notes>
    <notes id="FPar3">
      <title>Consent for publication</title>
      <p id="Par68">Not applicable.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Taft</surname>
            <given-names>RJ</given-names>
          </name>
          <name>
            <surname>Pang</surname>
            <given-names>KC</given-names>
          </name>
          <name>
            <surname>Mercer</surname>
            <given-names>TR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Non-coding RNAs: regulators of disease</article-title>
        <source>J Pathol</source>
        <year>2010</year>
        <volume>220</volume>
        <issue>2</issue>
        <fpage>126</fpage>
        <lpage>139</lpage>
        <pub-id pub-id-type="doi">10.1002/path.2638</pub-id>
        <?supplied-pmid 19882673?>
        <pub-id pub-id-type="pmid">19882673</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Long non-coding RNAs and complex diseases: from experimental results to computational models</article-title>
        <source>Brief Bioinform</source>
        <year>2017</year>
        <volume>18</volume>
        <issue>4</issue>
        <fpage>558</fpage>
        <lpage>576</lpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbw060</pub-id>
        <?supplied-pmid 27345524?>
        <pub-id pub-id-type="pmid">27345524</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Barsyte-Lovejoy</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lau</surname>
            <given-names>SK</given-names>
          </name>
          <name>
            <surname>Boutros</surname>
            <given-names>PC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The c-Myc oncogene directly induces the H19 noncoding RNAby allele-specific binding to potentiate tumorigenesis</article-title>
        <source>Cancer Res</source>
        <year>2006</year>
        <volume>66</volume>
        <issue>10</issue>
        <fpage>5330</fpage>
        <lpage>5337</lpage>
        <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-0037</pub-id>
        <?supplied-pmid 16707459?>
        <pub-id pub-id-type="pmid">16707459</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Bai</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Long non-coding RNA brain cytoplasmic RNA 1 acts as an oncogene and regulates cell proliferation and metastasis in non-small cell lung cancer</article-title>
        <source>J NanosciNanotechnol</source>
        <year>2019</year>
        <volume>19</volume>
        <issue>4</issue>
        <fpage>1978</fpage>
        <lpage>1985</lpage>
        <pub-id pub-id-type="doi">10.1166/jnn.2019.16402</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ji</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Diederichs</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer</article-title>
        <source>Oncogene</source>
        <year>2003</year>
        <volume>22</volume>
        <issue>39</issue>
        <fpage>8031</fpage>
        <lpage>8041</lpage>
        <pub-id pub-id-type="doi">10.1038/sj.onc.1206928</pub-id>
        <?supplied-pmid 12970751?>
        <pub-id pub-id-type="pmid">12970751</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway</article-title>
        <source>Mol Cancer</source>
        <year>2019</year>
        <volume>18</volume>
        <issue>1</issue>
        <fpage>84</fpage>
        <pub-id pub-id-type="doi">10.1186/s12943-019-1013-3</pub-id>
        <?supplied-pmid 30961617?>
        <pub-id pub-id-type="pmid">30961617</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hajjari</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Salavaty</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>HOTAIR: an oncogenic long non-coding RNA in different cancers</article-title>
        <source>Cancer Biol Med</source>
        <year>2015</year>
        <volume>12</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <lpage>9</lpage>
        <pub-id pub-id-type="doi">10.7497/j.issn.2095-3941.2015.0006</pub-id>
        <?supplied-pmid 25859406?>
        <pub-id pub-id-type="pmid">25859406</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhai</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>LncRNA-SARCC suppresses renal cell carcinoma (RCC) progression via altering the androgen receptor(AR)/miRNA-143-3p signals</article-title>
        <source>Cell Death Difier</source>
        <year>2017</year>
        <volume>24</volume>
        <issue>9</issue>
        <fpage>1502</fpage>
        <lpage>1517</lpage>
        <pub-id pub-id-type="doi">10.1038/cdd.2017.74</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hamilton</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Young</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jang</surname>
            <given-names>K</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>HOTAIRM1 lncRNA is downregulated in clear cell renal cell carcinoma and inhibits the hypoxia pathway</article-title>
        <source>Cancer Lett</source>
        <year>2020</year>
        <volume>472</volume>
        <fpage>50</fpage>
        <lpage>58</lpage>
        <pub-id pub-id-type="doi">10.1016/j.canlet.2019.12.022</pub-id>
        <?supplied-pmid 31862408?>
        <pub-id pub-id-type="pmid">31862408</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xie</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>NONCODEv4: exploring the world of long non-coding RNA genes</article-title>
        <source>Nucleic Acids Res</source>
        <year>2014</year>
        <volume>42</volume>
        <issue>Database issue</issue>
        <fpage>D98</fpage>
        <lpage>103</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkt1222</pub-id>
        <?supplied-pmid 24285305?>
        <pub-id pub-id-type="pmid">24285305</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>LncRNADisease: a database for long-non-coding RNA-associated diseases</article-title>
        <source>Nucleic Acids Res</source>
        <year>2013</year>
        <volume>41</volume>
        <issue>Database issue</issue>
        <fpage>D983</fpage>
        <lpage>D986</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gks1099</pub-id>
        <?supplied-pmid 23175614?>
        <pub-id pub-id-type="pmid">23175614</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Lnc2Cancer v2.0: updated database of experimentally supported long non-coding RNAs in human cancers</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D1028</fpage>
        <lpage>D1033</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky1096</pub-id>
        <?supplied-pmid 30407549?>
        <pub-id pub-id-type="pmid">30407549</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>ZH</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>GY</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>IRWRLDA: improved random walk with restart for lncRNA-disease association prediction</article-title>
        <source>Oncotarget</source>
        <year>2016</year>
        <volume>7</volume>
        <issue>36</issue>
        <fpage>57919</fpage>
        <lpage>57931</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.11141</pub-id>
        <?supplied-pmid 27517318?>
        <pub-id pub-id-type="pmid">27517318</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Liao</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Global network random walk for predicting potential human lncRNA-disease associations</article-title>
        <source>Sci Rep</source>
        <year>2017</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>12442</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-017-12763-z</pub-id>
        <?supplied-pmid 28963512?>
        <pub-id pub-id-type="pmid">28963512</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Shi</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network</article-title>
        <source>MolBiosyst</source>
        <year>2014</year>
        <volume>10</volume>
        <issue>8</issue>
        <fpage>2074</fpage>
        <lpage>2081</lpage>
        <pub-id pub-id-type="doi">10.1039/c3mb70608g</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>KATZLDA: KATZ measure for the lncRNA-disease association prediction</article-title>
        <source>Sci Rep</source>
        <year>2015</year>
        <volume>5</volume>
        <fpage>16840</fpage>
        <pub-id pub-id-type="doi">10.1038/srep16840</pub-id>
        <?supplied-pmid 26577439?>
        <pub-id pub-id-type="pmid">26577439</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>YA</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>ZH</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ILNCSIM: improved lncRNA functional similarity calculation model</article-title>
        <source>Oncotarget</source>
        <year>2016</year>
        <volume>7</volume>
        <issue>18</issue>
        <fpage>25902</fpage>
        <lpage>25914</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.8296</pub-id>
        <?supplied-pmid 27028993?>
        <pub-id pub-id-type="pmid">27028993</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A novel algorithm based on bi-random walks to identify disease-related lncRNAs</article-title>
        <source>BMC Bioinform</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>Suppl 18</issue>
        <fpage>569</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-019-3128-3</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A novel target convergence set based random walk with restart for prediction of potential LncRNA-disease associations</article-title>
        <source>BMC Bioinform</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>1</issue>
        <fpage>626</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-019-3216-4</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sumathipala</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Maiorino</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Weiss</surname>
            <given-names>ST</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Network diffusion approach to predict LncRNA disease associations using multi-type biological networks: LION</article-title>
        <source>Front Physiol</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>888</fpage>
        <pub-id pub-id-type="doi">10.3389/fphys.2019.00888</pub-id>
        <?supplied-pmid 31379598?>
        <pub-id pub-id-type="pmid">31379598</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Integrating multiple heterogeneous networks for novel LncRNA-Disease Association Inference</article-title>
        <source>IEEE/ACM Trans ComputBiolBioinform</source>
        <year>2019</year>
        <volume>16</volume>
        <issue>2</issue>
        <fpage>396</fpage>
        <lpage>406</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2017.2701379</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fan</surname>
            <given-names>XN</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>SW</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>SY</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Prediction of lncRNA-disease associations by integrating diverse heterogeneous information sources with RWR algorithm and positive pointwise mutual information</article-title>
        <source>BMC Bioinform</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>1</issue>
        <fpage>87</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-019-2675-y</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mamoshina</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Vieira</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Putin</surname>
            <given-names>E</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Applications of deep learning in biomedicine</article-title>
        <source>Mol Pharm</source>
        <year>2016</year>
        <volume>13</volume>
        <issue>5</issue>
        <fpage>1445</fpage>
        <lpage>1454</lpage>
        <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.5b00982</pub-id>
        <?supplied-pmid 27007977?>
        <pub-id pub-id-type="pmid">27007977</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Xi</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>LPGNMF: Predicting long non-coding RNA and protein interaction using graph regularized nonnegative matrix factorization</article-title>
        <source>IEEE/ACM Trans ComputBiolBioinform</source>
        <year>2020</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>189</fpage>
        <lpage>197</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2018.2861009</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Budach</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Marsico</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>pysster: classification of biological sequences by learning sequence and structure motifs with convolutional neural networks</article-title>
        <source>Bioinformatics</source>
        <year>2018</year>
        <volume>34</volume>
        <issue>17</issue>
        <fpage>3035</fpage>
        <lpage>3037</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bty222</pub-id>
        <?supplied-pmid 29659719?>
        <pub-id pub-id-type="pmid">29659719</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xuan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A novel collaborative filtering model for LncRNA-disease association prediction based on the Naïve Bayesian classifier</article-title>
        <source>BMC Bioinform</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>1</issue>
        <fpage>396</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-019-2985-0</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yao</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zhan</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhan</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A random forest based computational model for predicting novel lncRNA-disease associations</article-title>
        <source>BMC Bioinform</source>
        <year>2020</year>
        <volume>21</volume>
        <issue>1</issue>
        <fpage>126</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-020-3458-1</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Deng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>LDAH2V: exploring meta-paths across multiple networks for lncRNA-Disease Association Prediction</article-title>
        <source>IEEE/ACM Trans ComputBiolBioinform</source>
        <year>2021</year>
        <volume>18</volume>
        <issue>4</issue>
        <fpage>1572</fpage>
        <lpage>1581</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2019.2946257</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>GY</given-names>
          </name>
        </person-group>
        <article-title>Novel human lncRNA-disease association inference based on lncRNA expression profiles</article-title>
        <source>Bioinformatics</source>
        <year>2013</year>
        <volume>29</volume>
        <issue>20</issue>
        <fpage>2617</fpage>
        <lpage>2624</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btt426</pub-id>
        <?supplied-pmid 24002109?>
        <pub-id pub-id-type="pmid">24002109</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xie</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Meng</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>Y</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SKF-LDA: similarity kernel fusion for predicting lncRNA-Disease Association</article-title>
        <source>MolTher Nucleic Acids</source>
        <year>2019</year>
        <volume>18</volume>
        <fpage>45</fpage>
        <lpage>55</lpage>
        <pub-id pub-id-type="doi">10.1016/j.omtn.2019.07.022</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>FX</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Protein-protein interaction site prediction through combining local and global features with deep neural networks</article-title>
        <source>Bioinformatics</source>
        <year>2020</year>
        <volume>36</volume>
        <issue>4</issue>
        <fpage>1114</fpage>
        <lpage>1120</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btz699</pub-id>
        <?supplied-pmid 31593229?>
        <pub-id pub-id-type="pmid">31593229</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhao</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DeepLGP: a novel deep learning method for prioritizing lncRNA target genes</article-title>
        <source>Bioinformatics</source>
        <year>2020</year>
        <volume>36</volume>
        <issue>16</issue>
        <fpage>4466</fpage>
        <lpage>4472</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btaa428</pub-id>
        <?supplied-pmid 32467970?>
        <pub-id pub-id-type="pmid">32467970</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fei</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A deep learning framework for identifying essential proteins by integrating multiple types of biological information</article-title>
        <source>IEEE/ACM Trans ComputBiolBioinform</source>
        <year>2021</year>
        <volume>18</volume>
        <issue>1</issue>
        <fpage>296</fpage>
        <lpage>305</lpage>
        <pub-id pub-id-type="doi">10.1109/TCBB.2019.2897679</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xuan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dual convolutional neural networks with attention mechanisms based method for predicting disease-related lncRNA genes</article-title>
        <source>Front Genet</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>416</fpage>
        <pub-id pub-id-type="doi">10.3389/fgene.2019.00416</pub-id>
        <?supplied-pmid 31130990?>
        <pub-id pub-id-type="pmid">31130990</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xuan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Graph convolutional network and convolutional neural network based method for predicting lncRNA-Disease Associations</article-title>
        <source>Cells</source>
        <year>2019</year>
        <volume>8</volume>
        <issue>9</issue>
        <fpage>1012</fpage>
        <pub-id pub-id-type="doi">10.3390/cells8091012</pub-id>
      </element-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xuan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Sheng</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>CNNDLP: a method based on convolutional autoencoder and convolutional neural network with adjacent edge attention for predicting lncRNA-Disease Associations</article-title>
        <source>Int J Mol Sci</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>17</issue>
        <fpage>4260</fpage>
        <pub-id pub-id-type="doi">10.3390/ijms20174260</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xuan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Jia</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>LDAPred: a method based on information flow propagation and a convolutional neural network for the prediction of Disease-Associated lncRNAs</article-title>
        <source>Int J Mol Sci</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>18</issue>
        <fpage>4458</fpage>
        <pub-id pub-id-type="doi">10.3390/ijms20184458</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Liao</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>iLncRNAdis-FB: identify lncRNA-disease associations by fusing biological feature blocks through deep neural network</article-title>
        <source>IEEE/ACM Trans ComputBiolBioinform</source>
        <year>2020</year>
        <pub-id pub-id-type="doi">10.1109/TCBB.2020.2964221</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MLCDForest: multi-label classification with deep forest in disease prediction for long non-coding RNAs</article-title>
        <source>Brief Bioinform</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1093/bib/bbaa104</pub-id>
        <?supplied-pmid 34965586?>
        <pub-id pub-id-type="pmid">34965586</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>BiGAN: LncRNA-disease association prediction based on bidirectional generative adversarial network</article-title>
        <source>BMC Bioinform</source>
        <year>2021</year>
        <volume>22</volume>
        <issue>1</issue>
        <fpage>357</fpage>
        <pub-id pub-id-type="doi">10.1186/s12859-021-04273-7</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xuan</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A probabilistic matrix factorization method for identifying lncRNA-disease Associations</article-title>
        <source>Genes (Basel)</source>
        <year>2019</year>
        <volume>10</volume>
        <issue>2</issue>
        <fpage>126</fpage>
        <pub-id pub-id-type="doi">10.3390/genes10020126</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bian</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>DNILMF-LDA: prediction of lncRNA-disease associations by dual-network integrated logistic matrix factorization and bayesian optimization</article-title>
        <source>Genes (Basel)</source>
        <year>2019</year>
        <volume>10</volume>
        <issue>8</issue>
        <fpage>608</fpage>
        <pub-id pub-id-type="doi">10.3390/genes10080608</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Weighted matrix factorization on multi-relational data for LncRNA-disease association prediction</article-title>
        <source>Methods</source>
        <year>2020</year>
        <volume>173</volume>
        <fpage>32</fpage>
        <lpage>43</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ymeth.2019.06.015</pub-id>
        <?supplied-pmid 31226302?>
        <pub-id pub-id-type="pmid">31226302</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Predicting human lncRNA-disease associations based on geometric matrix completion</article-title>
        <source>IEEE J Biomed Health Inform</source>
        <year>2020</year>
        <volume>24</volume>
        <issue>8</issue>
        <fpage>2420</fpage>
        <lpage>2429</lpage>
        <pub-id pub-id-type="doi">10.1109/JBHI.2019.2958389</pub-id>
        <?supplied-pmid 31825885?>
        <pub-id pub-id-type="pmid">31825885</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gao</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>YL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Multi-label fusion collaborative matrix factorization for predicting LncRNA-Disease Associations</article-title>
        <source>IEEE J Biomed Health Inform</source>
        <year>2021</year>
        <volume>25</volume>
        <issue>3</issue>
        <fpage>881</fpage>
        <lpage>890</lpage>
        <pub-id pub-id-type="doi">10.1109/JBHI.2020.2988720</pub-id>
        <?supplied-pmid 32324583?>
        <pub-id pub-id-type="pmid">32324583</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>JX</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>YL</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>WGRCMF: a weighted graph regularized collaborative matrix factorization method for predicting novel LncRNA-Disease Associations</article-title>
        <source>IEEE J Biomed Health Inform</source>
        <year>2021</year>
        <volume>25</volume>
        <issue>1</issue>
        <fpage>257</fpage>
        <lpage>265</lpage>
        <pub-id pub-id-type="doi">10.1109/JBHI.2020.2985703</pub-id>
        <?supplied-pmid 32287024?>
        <pub-id pub-id-type="pmid">32287024</pub-id>
      </element-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Domeniconi</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Matrix factorization-based data fusion for the prediction of lncRNA-disease associations</article-title>
        <source>Bioinformatics</source>
        <year>2018</year>
        <volume>34</volume>
        <issue>9</issue>
        <fpage>1529</fpage>
        <lpage>1537</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btx794</pub-id>
        <?supplied-pmid 29228285?>
        <pub-id pub-id-type="pmid">29228285</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Prediction of lncRNA-disease associations based on inductive matrix completion</article-title>
        <source>Bioinformatics</source>
        <year>2018</year>
        <volume>34</volume>
        <issue>19</issue>
        <fpage>3357</fpage>
        <lpage>3364</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bty327</pub-id>
        <?supplied-pmid 29718113?>
        <pub-id pub-id-type="pmid">29718113</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>SDLDA: lncRNA-disease association prediction based on singular value decomposition and deep learning</article-title>
        <source>Methods</source>
        <year>2020</year>
        <volume>179</volume>
        <fpage>73</fpage>
        <lpage>80</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ymeth.2020.05.002</pub-id>
        <?supplied-pmid 32387314?>
        <pub-id pub-id-type="pmid">32387314</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fei</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DMFLDA: A deep learning framework for predicting IncRNA-disease associations</article-title>
        <source>IEEE/ACM Trans ComputBiolBioinform</source>
        <year>2020</year>
        <pub-id pub-id-type="doi">10.1109/TCBB.2020.2983958</pub-id>
      </element-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zitnik</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Agrawal</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Leskovec</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Modeling polypharmacy side effects with graph convolutional networks</article-title>
        <source>Bioinformatics</source>
        <year>2018</year>
        <volume>34</volume>
        <issue>13</issue>
        <fpage>i457</fpage>
        <lpage>i466</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bty294</pub-id>
        <?supplied-pmid 29949996?>
        <pub-id pub-id-type="pmid">29949996</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <mixed-citation publication-type="other">Han P, Yang P, Zhao PL. GCN-MF: disease-gene association identification by graph convolutional networks and matrix factorization. Proceedings of the 25th ACM SIGKDD International Conference. 2019;705–713. 10.1145/3292500.3330912.</mixed-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Silva</surname>
            <given-names>ABOV</given-names>
          </name>
          <name>
            <surname>Spinosa</surname>
            <given-names>EJ</given-names>
          </name>
        </person-group>
        <article-title>Graph convolutional auto-encoders for predicting novel lncRNA-Disease associations</article-title>
        <source>IEEE/ACM Trans ComputBiolBioinform</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1109/TCBB.2021.3070910</pub-id>
      </element-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>GCRFLDA: scoring lncRNA-disease associations using graph convolution matrix completion with conditional random field</article-title>
        <source>Brief Bioinform</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1093/bib/bbab361</pub-id>
        <?supplied-pmid 34718408?>
        <pub-id pub-id-type="pmid">34718408</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <mixed-citation publication-type="other">Kumaran R, Kalyani S, Ziad K. Link Prediction by Analyzing Common Neighbors Based Subgraphs using Convolutional Neural Network.The 24th European Conference on Artificial Intelligence. 2020.</mixed-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <mixed-citation publication-type="other">Zhang M and Chen Y. Link prediction based on graph neural networks. In: Advances in neural information processing systems. 2018:5165–5175.</mixed-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Feng</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The dysregulated expression of KCNQ1OT1 and Its interaction with downstream factors miR-145/CCNE2 in breast cancer cells</article-title>
        <source>Cell PhysiolBiochem</source>
        <year>2018</year>
        <volume>49</volume>
        <issue>2</issue>
        <fpage>432</fpage>
        <lpage>446</lpage>
        <pub-id pub-id-type="doi">10.1159/000492978</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ormandy</surname>
            <given-names>CJ</given-names>
          </name>
          <name>
            <surname>Musgrove</surname>
            <given-names>EA</given-names>
          </name>
          <name>
            <surname>Hui</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Cyclin D1, EMS1 and 11q13 amplification in breast cancer</article-title>
        <source>Breast Cancer Res Treat</source>
        <year>2003</year>
        <volume>78</volume>
        <issue>3</issue>
        <fpage>323</fpage>
        <lpage>335</lpage>
        <pub-id pub-id-type="doi">10.1023/a:1023033708204</pub-id>
        <?supplied-pmid 12755491?>
        <pub-id pub-id-type="pmid">12755491</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Su</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>miR-142 suppresses endometrial cancer proliferation in vitro and in vivo by targeting cyclin D1</article-title>
        <source>DNA Cell Biol</source>
        <year>2019</year>
        <volume>38</volume>
        <issue>2</issue>
        <fpage>144</fpage>
        <lpage>150</lpage>
        <pub-id pub-id-type="doi">10.1089/dna.2018.4441</pub-id>
        <?supplied-pmid 30585737?>
        <pub-id pub-id-type="pmid">30585737</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Noncoding RNAs in gastric cancer: implications for drug resistance</article-title>
        <source>Mol Cancer</source>
        <year>2020</year>
        <volume>19</volume>
        <issue>1</issue>
        <fpage>62</fpage>
        <pub-id pub-id-type="doi">10.1186/s12943-020-01185-7</pub-id>
        <?supplied-pmid 32192494?>
        <pub-id pub-id-type="pmid">32192494</pub-id>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Qian</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DLX6 antisense RNA 1 modulates glucose metabolism and cell growth in gastric cancer by targeting microRNA-4290</article-title>
        <source>Dig Dis Sci</source>
        <year>2021</year>
        <volume>66</volume>
        <issue>2</issue>
        <fpage>460</fpage>
        <lpage>473</lpage>
        <pub-id pub-id-type="doi">10.1007/s10620-020-06223-4</pub-id>
        <?supplied-pmid 32239379?>
        <pub-id pub-id-type="pmid">32239379</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>T</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis</article-title>
        <source>J Cell Mol Med</source>
        <year>2019</year>
        <volume>23</volume>
        <issue>1</issue>
        <fpage>29</fpage>
        <lpage>38</lpage>
        <pub-id pub-id-type="doi">10.1111/jcmm.13658</pub-id>
        <?supplied-pmid 30565858?>
        <pub-id pub-id-type="pmid">30565858</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>X</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Down-regulated long non-coding RNA H19 inhibits carcinogenesis of renal cell carcinoma</article-title>
        <source>Neoplasma</source>
        <year>2015</year>
        <volume>62</volume>
        <issue>3</issue>
        <fpage>412</fpage>
        <lpage>418</lpage>
        <pub-id pub-id-type="doi">10.4149/neo_2015_049</pub-id>
        <?supplied-pmid 25866221?>
        <pub-id pub-id-type="pmid">25866221</pub-id>
      </element-citation>
    </ref>
    <ref id="CR64">
      <label>64.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhou</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>An emerging understanding of long noncoding RNAs in kidney cancer</article-title>
        <source>J Cancer Res ClinOncol</source>
        <year>2014</year>
        <volume>140</volume>
        <issue>12</issue>
        <fpage>1989</fpage>
        <lpage>1995</lpage>
        <pub-id pub-id-type="doi">10.1007/s00432-014-1699-y</pub-id>
      </element-citation>
    </ref>
    <ref id="CR65">
      <label>65.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Guan</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Computational models for lncRNA function prediction and functional similarity calculation</article-title>
        <source>Brief Funct Genomics</source>
        <year>2019</year>
        <volume>18</volume>
        <issue>1</issue>
        <fpage>58</fpage>
        <lpage>82</lpage>
        <pub-id pub-id-type="doi">10.1093/bfgp/ely031</pub-id>
        <?supplied-pmid 30247501?>
        <pub-id pub-id-type="pmid">30247501</pub-id>
      </element-citation>
    </ref>
    <ref id="CR66">
      <label>66.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Qu</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Predicting miRNA–disease association based on inductive matrix completion</article-title>
        <source>Bioinformatics</source>
        <year>2018</year>
        <volume>34</volume>
        <issue>24</issue>
        <fpage>4256</fpage>
        <lpage>4265</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bty503</pub-id>
        <?supplied-pmid 29939227?>
        <pub-id pub-id-type="pmid">29939227</pub-id>
      </element-citation>
    </ref>
    <ref id="CR67">
      <label>67.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Qu</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MDHGI: matrix decomposition and heterogeneous graph inference for miRNA-disease association prediction</article-title>
        <source>PLoSComput Biol</source>
        <year>2018</year>
        <volume>14</volume>
        <issue>8</issue>
        <fpage>e1006418</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pcbi.1006418</pub-id>
      </element-citation>
    </ref>
    <ref id="CR68">
      <label>68.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Q</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MicroRNAs and complex diseases: from experimental results to computational models</article-title>
        <source>Brief Bioinform</source>
        <year>2019</year>
        <volume>20</volume>
        <issue>2</issue>
        <fpage>515</fpage>
        <lpage>539</lpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbx130</pub-id>
        <?supplied-pmid 29045685?>
        <pub-id pub-id-type="pmid">29045685</pub-id>
      </element-citation>
    </ref>
    <ref id="CR69">
      <label>69.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Menche</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kitsak</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Disease networks. Uncovering disease-disease relationships through the incomplete interactome</article-title>
        <source>Science</source>
        <year>2015</year>
        <volume>347</volume>
        <issue>6224</issue>
        <fpage>1257601</fpage>
        <pub-id pub-id-type="doi">10.1126/science.1257601</pub-id>
        <?supplied-pmid 25700523?>
        <pub-id pub-id-type="pmid">25700523</pub-id>
      </element-citation>
    </ref>
    <ref id="CR70">
      <label>70.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Piñero</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Bravo</surname>
            <given-names>À</given-names>
          </name>
          <name>
            <surname>Queralt-Rosinach</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants</article-title>
        <source>Nucleic Acids Res</source>
        <year>2017</year>
        <volume>45</volume>
        <issue>D1</issue>
        <fpage>D833</fpage>
        <lpage>D839</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkw943</pub-id>
        <?supplied-pmid 27924018?>
        <pub-id pub-id-type="pmid">27924018</pub-id>
      </element-citation>
    </ref>
    <ref id="CR71">
      <label>71.</label>
      <mixed-citation publication-type="other">Zhang M, Chen Y. Inductive matrix completion based on graph neural networks. International Conference on Learning Representations. 2020.</mixed-citation>
    </ref>
    <ref id="CR72">
      <label>72.</label>
      <mixed-citation publication-type="other">Zhang S, Xie L. Improving Attention Mechanism in Graph Neural Networks via Cardinality Preservation. International Joint Conference on Artificial Intelligence. 2020:1395–1402.</mixed-citation>
    </ref>
  </ref-list>
</back>
